{"add": {"doc": {"field": [{"@name": "docid", "#text": "BR-TU.14112"}, {"@name": "filename", "#text": "20379_fabris_als_dr_araca_par.pdf"}, {"@name": "filetype", "#text": "PDF"}, {"@name": "text", "#text": "RESSALVA \n\nAtendendo solicita\u00e7\u00e3o do(a) \nautor(a), o texto completo desta tese \nser\u00e1 disponibilizado somente a partir \n\nde 28/07/2017. \n\n\n\nANDR\u00c9\t\n \u00a0LUIS\t\n \u00a0DA\t\n \u00a0SILVA\t\n \u00a0FABRIS\t\n \u00a0\n\nAN\u00c1LISE\t\n \u00a0HISTOL\u00d3GICA,\t\n \u00a0\n\nIMUNOISTOQU\u00cdMICA\t\n \u00a0E\t\n \u00a0MORFOM\u00c9TRICA\t\n \u00a0DE\t\n \u00a0\n\nBI\u00d3PSIAS\t\n \u00a0DE\t\n \u00a0TECIDO\t\n \u00a0\u00d3SSEO\t\n \u00a0DE\t\n \u00a0PACIENTES\t\n \u00a0\n\nHIPERTENSOS\t\n \u00a0COMPENSADOS\t\n \u00a0\n\nAra\u00e7atuba\t\n \u00a0\u2013\t\n \u00a0S\u00e3o\t\n \u00a0Paulo\t\n \u00a0\n\n2016\t\n \u00a0\n\n\n\nANDR\u00c9\t\n \u00a0LUIS\t\n \u00a0DA\t\n \u00a0SILVA\t\n \u00a0FABRIS\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\nAN\u00c1LISE\t\n \u00a0HISTOL\u00d3GICA,\t\n \u00a0\n\nIMUNOISTOQU\u00cdMICA\t\n \u00a0E\t\n \u00a0MORFOM\u00c9TRICA\t\n \u00a0DE\t\n \u00a0\n\nBI\u00d3PSIAS\t\n \u00a0DE\t\n \u00a0TECIDO\t\n \u00a0\u00d3SSEO\t\n \u00a0DE\t\n \u00a0PACIENTES\t\n \u00a0\n\nHIPERTENSOS\t\n \u00a0COMPENSADOS\t\n \u00a0\n\nTese\t\n \u00a0apresentada\t\n \u00a0\u00e0\t\n \u00a0Faculdade\t\n \u00a0de\t\n \u00a0Odontologia\t\n \u00a0\ndo\t\n \u00a0 Campus\t\n \u00a0 de\t\n \u00a0 Ara\u00e7atuba\t\n \u00a0 \u2013\t\n \u00a0 Universidade\t\n \u00a0\nEstadual\t\n \u00a0 Paulista\t\n \u00a0 \u201cJ\u00falio\t\n \u00a0 de\t\n \u00a0 Mesquita\t\n \u00a0 Filho\u201d-\u00ad?\t\n \u00a0\nUNESP,\t\n \u00a0 para\t\n \u00a0 obten\u00e7\u00e3o\t\n \u00a0 do\t\n \u00a0 T\u00edtulo\t\n \u00a0 de\t\n \u00a0 DOUTOR\t\n \u00a0\nEM\t\n \u00a0ODONTOLOGIA\t\n \u00a0(\u00c1rea\t\n \u00a0de\t\n \u00a0concentra\u00e7\u00e3o\t\n \u00a0em\t\n \u00a0\nCirurgia\t\n \u00a0e\t\n \u00a0Traumatologia\t\n \u00a0Bucomaxilofacial).\t\n \u00a0\n\n\t\n \u00a0\n\nOrientador:\t\n \u00a0Profa.\t\n \u00a0Ass.\t\n \u00a0Dra.\t\n \u00a0Roberta\t\n \u00a0Okamoto\t\n \u00a0\n\nCoorientador:\t\n \u00a0Prof.\t\n \u00a0Ass.\t\n \u00a0Dr.\t\n \u00a0Leonardo\t\n \u00a0Perez\t\n \u00a0Faverani\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\nAra\u00e7atuba\t\n \u00a0\u2013\t\n \u00a0S\u00e3o\t\n \u00a0Paulo\t\n \u00a0\n\n2016\n\n\t\n \u00a0\n\t\n \u00a0\n\t\n \u00a0\n\t\n \u00a0\n\t\n \u00a0\n\t\n \u00a0\n\t\n \u00a0\n\n\n\nCataloga\u00e7\u00e3o na Publica\u00e7\u00e3o (CIP) \n\nDiretoria T\u00e9cnica de Biblioteca e Documenta\u00e7\u00e3o \u2013 FOA / UNESP \n\nFabris,Andr\u00e9 Lu\u00eds da Silva. \n\nF128a An\u00e1lise histol\u00f3gica, imunoistoqu\u00edmica e morfom\u00e9trica de \nbi\u00f3psias de tecido \u00f3sseo de pacientes hipertensos compensados \n\nAndr\u00e9 Lu\u00eds da Silva Fabris. - Ara\u00e7atuba, 2016 \n\n66f. : il. + 1 CD-ROM \n\n Tese (Doutorado) \u2013 Universidade Estadual Paulista, \n\nFaculdade de Odontologia de Ara\u00e7atuba \n\nOrientadora: Profa. Roberta Okamoto \n\nCoorientador: Prof.Leonardo Perez Faverani \n\n1.Hipertens\u00e3o2. Implantes dent\u00e1rios3. Osso e ossos\n\nI. T.\n\nBlack D7 \n\nCDD 617.64 \n\n\n\n\t\n \u00a0\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\nDEDICAT\u00d3RIA\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\n\n\t\n \u00a0\n\t\n \u00a0\n\n\t\n \u00a0\n\nDedicat\u00f3ria\t\n \u00a0\n\n\t\n \u00a0\n\nDedico\t\n \u00a0esta\t\n \u00a0tese\t\n \u00a0\u00e0s\t\n \u00a0pessoas\t\n \u00a0mais\t\n \u00a0importantes\t\n \u00a0para\t\n \u00a0mim:\t\n \u00a0aos\t\n \u00a0meus\t\n \u00a0pais\t\n \u00a0Ab\u00edlio\t\n \u00a0Fabris\t\n \u00a0(in\t\n \u00a0\n\nMemorian),\t\n \u00a0por\u00e9m\t\n \u00a0vivo\t\n \u00a0em\t\n \u00a0mim,\t\n \u00a0e\t\n \u00a0Maria\t\n \u00a0Ivone\t\n \u00a0da\t\n \u00a0Silva\t\n \u00a0Fabris\t\n \u00a0(Dona\t\n \u00a0Ivone)\t\n \u00a0por\t\n \u00a0me\t\n \u00a0ajudarem\t\n \u00a0\n\nsempre\t\n \u00a0durante\t\n \u00a0minha\t\n \u00a0caminhada\t\n \u00a0sendo\t\n \u00a0t\u00e3o\t\n \u00a0especiais\t\n \u00a0n\u00e3o\t\n \u00a0s\u00f3\t\n \u00a0na\t\n \u00a0minha\t\n \u00a0forma\u00e7\u00e3o,\t\n \u00a0educa\u00e7\u00e3o,\t\n \u00a0\n\nmas\t\n \u00a0me\t\n \u00a0ensinando\t\n \u00a0a\t\n \u00a0ser\t\n \u00a0uma\t\n \u00a0pessoa\t\n \u00a0melhor,\t\n \u00a0justa\t\n \u00a0e\t\n \u00a0honesta.\t\n \u00a0S\u00f3\t\n \u00a0uma\t\n \u00a0palavra\t\n \u00a0que\t\n \u00a0resume\t\n \u00a0isso,\t\n \u00a0\n\nAmor.\t\n \u00a0 Aos\t\n \u00a0 meus\t\n \u00a0 irm\u00e3os\t\n \u00a0 Rodrigo\t\n \u00a0 da\t\n \u00a0 Silva\t\n \u00a0 Fabris\t\n \u00a0 e\t\n \u00a0 Gustavo\t\n \u00a0 da\t\n \u00a0 Silva\t\n \u00a0 Fabris\t\n \u00a0 por\t\n \u00a0 sempre\t\n \u00a0 me\t\n \u00a0\n\napoiarem\t\n \u00a0em\t\n \u00a0todas\t\n \u00a0as\t\n \u00a0fases\t\n \u00a0da\t\n \u00a0minha\t\n \u00a0vida,\t\n \u00a0me\t\n \u00a0amparando\t\n \u00a0nas\t\n \u00a0dificuldades\t\n \u00a0ensinando\t\n \u00a0a\t\n \u00a0ter\t\n \u00a0\n\npaci\u00eancia,\t\n \u00a0perseveran\u00e7a\t\n \u00a0e\t\n \u00a0uma\t\n \u00a0for\u00e7a\t\n \u00a0no\t\n \u00a0qual\t\n \u00a0nos\t\n \u00a0une\t\n \u00a0de\t\n \u00a0forma\t\n \u00a0extraordin\u00e1ria.\t\n \u00a0\n\nAos\t\n \u00a0meus\t\n \u00a0tios\t\n \u00a0Jos\u00e9\t\n \u00a0Alberto\t\n \u00a0da\t\n \u00a0Silva\t\n \u00a0(Z\u00e9\t\n \u00a0Branco)\t\n \u00a0e\t\n \u00a0Claudineia\t\n \u00a0Green\t\n \u00a0Silva\t\n \u00a0por\t\n \u00a0cuidarem\t\n \u00a0\n\nde\t\n \u00a0 mim\t\n \u00a0 de\t\n \u00a0 forma\t\n \u00a0 t\u00e3o\t\n \u00a0 especial\t\n \u00a0 durante\t\n \u00a0 um\t\n \u00a0 per\u00edodo\t\n \u00a0 no\t\n \u00a0 qual\t\n \u00a0 ingressei\t\n \u00a0 na\t\n \u00a0 odontologia\t\n \u00a0 e\t\n \u00a0 me\t\n \u00a0\n\nacolheram\t\n \u00a0na\t\n \u00a0casa\t\n \u00a0de\t\n \u00a0voc\u00eas\t\n \u00a0como\t\n \u00a0um\t\n \u00a0filho,\t\n \u00a0tendo\t\n \u00a0uma\t\n \u00a0gratid\u00e3o\t\n \u00a0eterna.\t\n \u00a0\n\nTia\t\n \u00a0 S\u00f4nia\t\n \u00a0 Maria\t\n \u00a0 da\t\n \u00a0 Silva\t\n \u00a0 sendo\t\n \u00a0 minha\t\n \u00a0 segunda\t\n \u00a0 m\u00e3e,\t\n \u00a0 cuidando\t\n \u00a0 de\t\n \u00a0 tudo\t\n \u00a0 e\t\n \u00a0 de\t\n \u00a0 todos\t\n \u00a0\n\nabdicando\t\n \u00a0 de\t\n \u00a0 suas\t\n \u00a0 pr\u00f3prias\t\n \u00a0 coisas\t\n \u00a0 para\t\n \u00a0 cuidar\t\n \u00a0 dos\t\n \u00a0 demais.\t\n \u00a0 Deixo\t\n \u00a0 aqui\t\n \u00a0 meu\t\n \u00a0 sentimento\t\n \u00a0 de\t\n \u00a0\n\namor\t\n \u00a0por\t\n \u00a0voc\u00ea.\t\n \u00a0\n\nTio\t\n \u00a0 Paulo\t\n \u00a0 Roberto\t\n \u00a0 da\t\n \u00a0 Silva\t\n \u00a0 uma\t\n \u00a0 pessoa\t\n \u00a0 especial\t\n \u00a0 que\t\n \u00a0 sempre\t\n \u00a0 mostrou\t\n \u00a0 a\t\n \u00a0 todos\t\n \u00a0 sua\t\n \u00a0\n\nhonestidade,\t\n \u00a0seriedade\t\n \u00a0e\t\n \u00a0compromisso\t\n \u00a0me\t\n \u00a0ajudando\t\n \u00a0na\t\n \u00a0forma\u00e7\u00e3o\t\n \u00a0de\t\n \u00a0meu\t\n \u00a0car\u00e1ter.\t\n \u00a0Deixo\t\n \u00a0aqui\t\n \u00a0\n\nmeu\t\n \u00a0profundo\t\n \u00a0abra\u00e7o.\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\n\n\t\n \u00a0\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\nAGRADECIMENTOS\t\n \u00a0\n\n\t\n \u00a0ESPECIAIS\t\n \u00a0\n\t\n \u00a0\n\n\n\n\t\n \u00a0\n\n\t\n \u00a0\n\nAgradecimentos\t\n \u00a0Especiais\t\n \u00a0\n\nA\t\n \u00a0minha\t\n \u00a0orientadora,\t\n \u00a0Professora\t\n \u00a0Assistente\t\n \u00a0Doutora\t\n \u00a0Roberta\t\n \u00a0Okamoto.\t\n \u00a0Agrade\u00e7o\t\n \u00a0o\t\n \u00a0\n\napoio,\t\n \u00a0 a\t\n \u00a0 amizade,\t\n \u00a0 a\t\n \u00a0 disponibilidade,\t\n \u00a0 a\t\n \u00a0 partilha\t\n \u00a0 do\t\n \u00a0 saber\t\n \u00a0 e\t\n \u00a0 as\t\n \u00a0 valiosas\t\n \u00a0 contribui\u00e7\u00f5es\t\n \u00a0 para\t\n \u00a0 o\t\n \u00a0\n\ntrabalho.\t\n \u00a0Acima\t\n \u00a0de\t\n \u00a0tudo,\t\n \u00a0obrigado\t\n \u00a0por\t\n \u00a0me\t\n \u00a0acompanhar\t\n \u00a0nesta\t\n \u00a0jornada\t\n \u00a0e\t\n \u00a0por\t\n \u00a0estimular\t\n \u00a0o\t\n \u00a0meu\t\n \u00a0\n\ninteresse\t\n \u00a0pelo\t\n \u00a0conhecimento\t\n \u00a0e\t\n \u00a0vida\t\n \u00a0acad\u00eamica,\t\n \u00a0que\t\n \u00a0me\t\n \u00a0recebeu\t\n \u00a0sempre\t\n \u00a0de\t\n \u00a0bra\u00e7os\t\n \u00a0abertos\t\n \u00a0e\t\n \u00a0\n\ncom\t\n \u00a0 um\t\n \u00a0 sorriso\t\n \u00a0 estampado\t\n \u00a0 no\t\n \u00a0 rosto,\t\n \u00a0 constantemente\t\n \u00a0 dispon\u00edvel\t\n \u00a0 para\t\n \u00a0 resolver\t\n \u00a0 os\t\n \u00a0 meus\t\n \u00a0\n\nproblemas,\t\n \u00a0indecis\u00f5es\t\n \u00a0e\t\n \u00a0impasses\t\n \u00a0\n\nAo\t\n \u00a0Prof.\t\n \u00a0Adj.\t\n \u00a0Idelmo\t\n \u00a0Rangel\t\n \u00a0Garcia\t\n \u00a0J\u00fanior.\t\n \u00a0Uma\t\n \u00a0pessoa\t\n \u00a0iluminada,\t\n \u00a0no\t\n \u00a0qual\t\n \u00a0n\u00e3o\t\n \u00a0mede\t\n \u00a0\n\nesfor\u00e7os\t\n \u00a0para\t\n \u00a0ajudar\t\n \u00a0o\t\n \u00a0pr\u00f3ximo,\t\n \u00a0ser\t\n \u00a0mestre\t\n \u00a0\u00e9\t\n \u00a0o\t\n \u00a0seu\t\n \u00a0dom.\t\n \u00a0Meu\t\n \u00a0muito\t\n \u00a0obrigado\t\n \u00a0e\t\n \u00a0receba\t\n \u00a0meu\t\n \u00a0\n\ncarinho!\t\n \u00a0\n\nAo\t\n \u00a0Prof.\t\n \u00a0Titular\t\n \u00a0Tetuo\t\n \u00a0Okamoto\t\n \u00a0(in\t\n \u00a0memorian).\t\n \u00a0\t\n \u00a0Desde\t\n \u00a0a\t\n \u00a0minha\t\n \u00a0gradua\u00e7\u00e3o\t\n \u00a0esteve\t\n \u00a0ao\t\n \u00a0\n\nmeu\t\n \u00a0lado\t\n \u00a0segurando\t\n \u00a0minha\t\n \u00a0m\u00e3o\t\n \u00a0durante\t\n \u00a0cirugias,\t\n \u00a0tendo\t\n \u00a0como\t\n \u00a0espelho\t\n \u00a0e\t\n \u00a0um\t\n \u00a0exemplo\t\n \u00a0de\t\n \u00a0vida\t\n \u00a0\n\ncomo\t\n \u00a0pessoa\t\n \u00a0e\t\n \u00a0como\t\n \u00a0pesquisador.\t\n \u00a0Ao\t\n \u00a0Prof.\t\n \u00a0Ruy\t\n \u00a0dos\t\n \u00a0Santos\t\n \u00a0Pinto\t\n \u00a0minha\t\n \u00a0sincera\t\n \u00a0gratid\u00e3o\t\n \u00a0por\t\n \u00a0\n\nme\t\n \u00a0proporcionar\t\n \u00a0momentos\t\n \u00a0de\t\n \u00a0extrema\t\n \u00a0felicidade\t\n \u00a0durante\t\n \u00a0atendimentos\t\n \u00a0no\t\n \u00a0CAOE\t\n \u00a0\u00a8centrinho\u00a8\t\n \u00a0\n\num\t\n \u00a0lugar\t\n \u00a0onde\t\n \u00a0pacientes\t\n \u00a0recebem\t\n \u00a0amor\t\n \u00a0de\t\n \u00a0forma\t\n \u00a0plena.\t\n \u00a0\n\nAo\t\n \u00a0Professor\t\n \u00a0Adj\t\n \u00a0Osvaldo\t\n \u00a0Magro\t\n \u00a0Filho,\t\n \u00a0por\t\n \u00a0ser\t\n \u00a0um\t\n \u00a0exemplo\t\n \u00a0de\t\n \u00a0professor\t\n \u00a0para\t\n \u00a0todos\t\n \u00a0os\t\n \u00a0\n\nalunos\t\n \u00a0da\t\n \u00a0FOA.\t\n \u00a0Sempre\t\n \u00a0extremamente\t\n \u00a0carinhoso\t\n \u00a0no\t\n \u00a0qual\t\n \u00a0me\t\n \u00a0recepcionou\t\n \u00a0com\t\n \u00a0um\t\n \u00a0aperto\t\n \u00a0de\t\n \u00a0\n\nm\u00e3o,\t\n \u00a0palavras\t\n \u00a0de\t\n \u00a0conforto\t\n \u00a0e\t\n \u00a0tranquilidade,\t\n \u00a0nos\t\n \u00a0mostra\t\n \u00a0o\t\n \u00a0caminho\t\n \u00a0desta\t\n \u00a0linda\t\n \u00a0profiss\u00e3o.\t\n \u00a0Muito\t\n \u00a0\n\nobrigado\t\n \u00a0pelo\t\n \u00a0incentivo\t\n \u00a0e\t\n \u00a0ensinos.\t\n \u00a0Receba\t\n \u00a0minha\t\n \u00a0admira\u00e7\u00e3o!\t\n \u00a0\n\nAo\t\n \u00a0meu\t\n \u00a0coorientador\t\n \u00a0Professor\t\n \u00a0Assistente\t\n \u00a0Dr.\t\n \u00a0Leonardo\t\n \u00a0Perez\t\n \u00a0Faverani.\t\n \u00a0Um\t\n \u00a0amigo\t\n \u00a0\n\nespecial\t\n \u00a0 e\t\n \u00a0 agora\t\n \u00a0 professor\t\n \u00a0 desta\t\n \u00a0 institui\u00e7\u00e3o\t\n \u00a0 t\u00e3o\t\n \u00a0 respeitada,\t\n \u00a0 merecedor\t\n \u00a0 de\t\n \u00a0 estar\t\n \u00a0 trilhando\t\n \u00a0 o\t\n \u00a0\n\ncaminho\t\n \u00a0da\t\n \u00a0doc\u00eancia\t\n \u00a0com\t\n \u00a0extrema\t\n \u00a0compet\u00eancia\t\n \u00a0e\t\n \u00a0brilho,\t\n \u00a0deixo\t\n \u00a0aqui\t\n \u00a0meu\t\n \u00a0abra\u00e7o\t\n \u00a0especial.\t\n \u00a0\n\nAo\t\n \u00a0Professor\t\n \u00a0Assistente\t\n \u00a0Dr.\t\n \u00a0Francisley\t\n \u00a0\u00c1vila\t\n \u00a0Souza.\t\n \u00a0Por\t\n \u00a0v\u00e1rias\t\n \u00a0conversas\t\n \u00a0de\t\n \u00a0incentivo\t\n \u00a0\n\npela\t\n \u00a0 confian\u00e7a\t\n \u00a0 e\t\n \u00a0 a\t\n \u00a0 oportunidade\t\n \u00a0 em\t\n \u00a0 abrir\t\n \u00a0 caminhos\t\n \u00a0 aonde\t\n \u00a0 jamais\t\n \u00a0 havia\t\n \u00a0 pensado\t\n \u00a0 seguir,\t\n \u00a0\n\n\n\n8\t\n \u00a0\n\t\n \u00a0\n\n\t\n \u00a0\n\nmesmo\t\n \u00a0sem\t\n \u00a0me\t\n \u00a0conhecer.\t\n \u00a0Agrade\u00e7o\t\n \u00a0por\t\n \u00a0sempre\t\n \u00a0me\t\n \u00a0ajudar\t\n \u00a0em\t\n \u00a0tudo.\t\n \u00a0Saiba\t\n \u00a0que\t\n \u00a0\u00e9\t\n \u00a0uma\t\n \u00a0d\u00e1diva\t\n \u00a0a\t\n \u00a0\n\nconfian\u00e7a\t\n \u00a0depositada\t\n \u00a0em\t\n \u00a0mim.\t\n \u00a0\n\nA\t\n \u00a0Professora\t\n \u00a0Assistente\t\n \u00a0Doutora\t\n \u00a0Alessandra\t\n \u00a0Marcondes\t\n \u00a0Aranega.\t\n \u00a0Muito\t\n \u00a0obrigado\t\n \u00a0por\t\n \u00a0\n\ntodo\t\n \u00a0o\t\n \u00a0carinho\t\n \u00a0e\t\n \u00a0amizade\t\n \u00a0que\t\n \u00a0me\t\n \u00a0manifestou.\t\n \u00a0Agrade\u00e7o,\t\n \u00a0de\t\n \u00a0forma\t\n \u00a0especial,\t\n \u00a0a\t\n \u00a0ajuda,\t\n \u00a0o\t\n \u00a0apoio\t\n \u00a0e\t\n \u00a0\n\na\t\n \u00a0preocupa\u00e7\u00e3o,\t\n \u00a0nos\t\n \u00a0momentos\t\n \u00a0de\t\n \u00a0maior\t\n \u00a0afli\u00e7\u00e3o.\t\n \u00a0\n\nAos\t\n \u00a0Professores\t\n \u00a0da\t\n \u00a0Disciplina\t\n \u00a0da\t\n \u00a0Cirurgia\t\n \u00a0e\t\n \u00a0Traumatologia\t\n \u00a0Bucomaxilofacial\t\n \u00a0Daniela\t\n \u00a0\n\nPonzoni\t\n \u00a0 e\t\n \u00a0 Ana\t\n \u00a0 Paula\t\n \u00a0 Farnezi\t\n \u00a0 Bassi,\t\n \u00a0 pela\t\n \u00a0 amizade\t\n \u00a0 desfrutada\t\n \u00a0 em\t\n \u00a0 nosso\t\n \u00a0 departamento.\t\n \u00a0\n\nRecebam\t\n \u00a0o\t\n \u00a0meu\t\n \u00a0carinho\t\n \u00a0e\t\n \u00a0admira\u00e7\u00e3o.\t\n \u00a0\n\nAo\t\n \u00a0 Professor\t\n \u00a0 Wilson\t\n \u00a0 Roberto\t\n \u00a0 Poi,\t\n \u00a0 pelo\t\n \u00a0 maior\t\n \u00a0 exemplo\t\n \u00a0 do\t\n \u00a0 \u201cSer\t\n \u00a0 Professor\u201d.\t\n \u00a0 Muito\t\n \u00a0\n\nobrigado\t\n \u00a0por\t\n \u00a0fazer\t\n \u00a0parte\t\n \u00a0da\t\n \u00a0minha\t\n \u00a0forma\u00e7\u00e3o\t\n \u00a0e\t\n \u00a0me\t\n \u00a0fazer\t\n \u00a0descobrir\t\n \u00a0o\t\n \u00a0professor\t\n \u00a0que\t\n \u00a0est\u00e1\t\n \u00a0em\t\n \u00a0\n\nmim.\t\n \u00a0\t\n \u00a0\n\nAo\t\n \u00a0Professor\t\n \u00a0Claudio\t\n \u00a0Maldonado\t\n \u00a0Pastori,\t\n \u00a0um\t\n \u00a0professor\t\n \u00a0e\t\n \u00a0acima\t\n \u00a0de\t\n \u00a0tudo\t\n \u00a0uma\t\n \u00a0pessoa\t\n \u00a0\n\nextremamente\t\n \u00a0humana,\t\n \u00a0educada,\t\n \u00a0sol\u00edcita\t\n \u00a0e\t\n \u00a0que\t\n \u00a0sempre\t\n \u00a0me\t\n \u00a0inspirou\t\n \u00a0durante\t\n \u00a0a\t\n \u00a0resid\u00eancia\t\n \u00a0a\t\n \u00a0\n\nsermos\t\n \u00a0cirurgi\u00f5es\t\n \u00a0melhores.\t\n \u00a0Deixo\t\n \u00a0aqui\t\n \u00a0um\t\n \u00a0abra\u00e7o\t\n \u00a0forte\t\n \u00a0e\t\n \u00a0minha\t\n \u00a0gratid\u00e3o.\t\n \u00a0\n\nAo\t\n \u00a0 professor\t\n \u00a0 Paulo\t\n \u00a0 Roberto\t\n \u00a0 Botacin,\t\n \u00a0 uma\t\n \u00a0 pessoa\t\n \u00a0 extremamente\t\n \u00a0 contagiante,\t\n \u00a0\n\nmaravilhosa\t\n \u00a0e\t\n \u00a0educada,\t\n \u00a0sempre\t\n \u00a0preocupado\t\n \u00a0com\t\n \u00a0a\t\n \u00a0forma\u00e7\u00e3o\t\n \u00a0dos\t\n \u00a0alunos,\t\n \u00a0mas\t\n \u00a0nunca\t\n \u00a0deixando\t\n \u00a0\n\nde\t\n \u00a0ser\t\n \u00a0amigo.\t\n \u00a0Deixo\t\n \u00a0aqui\t\n \u00a0meu\t\n \u00a0abra\u00e7o.\t\n \u00a0\n\nA\t\n \u00a0professora\t\n \u00a0Ass.\t\n \u00a0Dra\t\n \u00a0Ana\t\n \u00a0Claudia\t\n \u00a0Rossi,\t\n \u00a0pela\t\n \u00a0educa\u00e7\u00e3o,\t\n \u00a0empenho\t\n \u00a0e\t\n \u00a0disponibilidade\t\n \u00a0\n\nem\t\n \u00a0aceitar\t\n \u00a0o\t\n \u00a0convite\t\n \u00a0para\t\n \u00a0formar\t\n \u00a0a\t\n \u00a0banca\t\n \u00a0examinadora\t\n \u00a0em\t\n \u00a0um\t\n \u00a0momento\t\n \u00a0impar\t\n \u00a0para\t\n \u00a0minha\t\n \u00a0\n\nforma\u00e7\u00e3o,\t\n \u00a0muito\t\n \u00a0obrigado.\t\n \u00a0Estendo\t\n \u00a0meus\t\n \u00a0agradecimentos\t\n \u00a0ao\t\n \u00a0Professor\t\n \u00a0Alexandre\t\n \u00a0Freire,\t\n \u00a0pela\t\n \u00a0\n\npronta\t\n \u00a0 disposi\u00e7\u00e3o\t\n \u00a0 na\t\n \u00a0 interpreta\u00e7\u00e3o\t\n \u00a0 dos\t\n \u00a0 dados\t\n \u00a0 microtomogr\u00e1ficos\t\n \u00a0 e\t\n \u00a0 das\t\n \u00a0 imagens\t\n \u00a0\n\ntridimensionais\t\n \u00a0deste\t\n \u00a0trabalho.\t\n \u00a0Assim,\t\n \u00a0agrade\u00e7o\t\n \u00a0a\t\n \u00a0Faculdade\t\n \u00a0de\t\n \u00a0Odontologia\t\n \u00a0de\t\n \u00a0Piracicaba\t\n \u00a0-\u00ad?\t\n \u00a0\n\nUNICAMP\t\n \u00a0pela\t\n \u00a0facilita\u00e7\u00e3o\t\n \u00a0destas\t\n \u00a0an\u00e1lises.\t\n \u00a0\n\nAos\t\n \u00a0professores\t\n \u00a0da\t\n \u00a0Disciplina\t\n \u00a0de\t\n \u00a0Cl\u00ednica\t\n \u00a0Integrada\t\n \u00a0(S\u00f4nia\t\n \u00a0Regina\t\n \u00a0Panzarini\t\n \u00a0Barioni,\t\n \u00a0\n\nDenise\t\n \u00a0 Pedrini,\t\n \u00a0 Daniela\t\n \u00a0 Brandini\t\n \u00a0 e\t\n \u00a0 Celso\t\n \u00a0 Sonoda),\t\n \u00a0 por\t\n \u00a0 serem\t\n \u00a0 os\t\n \u00a0 maiores\t\n \u00a0 exemplos\t\n \u00a0 de\t\n \u00a0\n\n\n\n9\t\n \u00a0\n\t\n \u00a0\n\n\t\n \u00a0\n\nprofessores.\t\n \u00a0Pela\t\n \u00a0disposi\u00e7\u00e3o\t\n \u00a0e\t\n \u00a0empenho\t\n \u00a0com\t\n \u00a0o\t\n \u00a0crescimento\t\n \u00a0da\t\n \u00a0nossa\t\n \u00a0faculdade.\t\n \u00a0Pelo\t\n \u00a0cuidado\t\n \u00a0\n\nno\t\n \u00a0trato\t\n \u00a0com\t\n \u00a0os\t\n \u00a0alunos\t\n \u00a0da\t\n \u00a0gradua\u00e7\u00e3o\t\n \u00a0e\t\n \u00a0da\t\n \u00a0p\u00f3s-\u00ad?gradua\u00e7\u00e3o.\t\n \u00a0Voc\u00eas\t\n \u00a0s\u00e3o\t\n \u00a0mestres\t\n \u00a0por\t\n \u00a0excel\u00eancia.\t\n \u00a0\n\nRecebam\t\n \u00a0minha\t\n \u00a0eterna\t\n \u00a0gratid\u00e3o,\t\n \u00a0carinho\t\n \u00a0e\t\n \u00a0admira\u00e7\u00e3o\t\n \u00a0neste\t\n \u00a0momento.\t\n \u00a0\n\n\u00c0\t\n \u00a0\u201cSass\u00e1\u201d\t\n \u00a0(Sabrina\t\n \u00a0Ferreira),\t\n \u00a0pelo\t\n \u00a0imenso\t\n \u00a0respeito\t\n \u00a0e\t\n \u00a0carinho\t\n \u00a0que\t\n \u00a0existe\t\n \u00a0entre\t\n \u00a0n\u00f3s.\t\n \u00a0O\t\n \u00a0\n\nDoutorado\t\n \u00a0 n\u00e3o\t\n \u00a0 seria\t\n \u00a0 t\u00e3o\t\n \u00a0 legal\t\n \u00a0 sem\t\n \u00a0 a\t\n \u00a0 sua\t\n \u00a0 presen\u00e7a.\t\n \u00a0 Uma\t\n \u00a0 menina\t\n \u00a0 especial,\t\n \u00a0 competente,\t\n \u00a0\n\ndedicada\t\n \u00a0e\t\n \u00a0que\t\n \u00a0tem\t\n \u00a0um\t\n \u00a0futuro\t\n \u00a0brilhante\t\n \u00a0pela\t\n \u00a0frente,\t\n \u00a0pois\t\n \u00a0do\t\n \u00a0fundo\t\n \u00a0do\t\n \u00a0cora\u00e7\u00e3o\t\n \u00a0desejo\t\n \u00a0o\t\n \u00a0melhor\t\n \u00a0\n\npra\t\n \u00a0voc\u00ea\t\n \u00a0minha\t\n \u00a0amiga.\t\n \u00a0\n\n\u00c0\t\n \u00a0\u201cJu\t\n \u00a0Zorzi\u201d\t\n \u00a0(Juliana\t\n \u00a0Zorzi\t\n \u00a0Colete),\t\n \u00a0pelo\t\n \u00a0respeito,\t\n \u00a0amor\t\n \u00a0e\t\n \u00a0amizade.\t\n \u00a0Obrigado\t\n \u00a0por\t\n \u00a0estar\t\n \u00a0\n\nao\t\n \u00a0meu\t\n \u00a0lado.\t\n \u00a0\n\n\u00c0\t\n \u00a0\u201cPili\u201d\t\n \u00a0(Maria\t\n \u00a0del\t\n \u00a0Pilar),\t\n \u00a0pela\t\n \u00a0amizade,\t\n \u00a0carinho\t\n \u00a0e\t\n \u00a0alegria\t\n \u00a0que\t\n \u00a0voc\u00ea\t\n \u00a0irradia.\t\n \u00a0Receba\t\n \u00a0meu\t\n \u00a0\n\ncarinho!\t\n \u00a0\n\nAos\t\n \u00a0amigos\t\n \u00a0da\t\n \u00a0p\u00f3s\t\n \u00a0gradua\u00e7\u00e3o,\t\n \u00a0Valthierre,\t\n \u00a0Jo\u00e3o\t\n \u00a0Paulo,\t\n \u00a0Erik,\t\n \u00a0Pedro,\t\n \u00a0Leonardo,\t\n \u00a0Heldo,\t\n \u00a0\n\nCarulina,\t\n \u00a0Wilian,\t\n \u00a0Ricardo,\t\n \u00a0Tarik,\t\n \u00a0Igor,\t\n \u00a0Gabriel,\t\n \u00a0Andr\u00e9,\t\n \u00a0Ciro,\t\n \u00a0Jhonathan,\t\n \u00a0Rodrigo,\t\n \u00a0Sormani\t\n \u00a0,\t\n \u00a0por\t\n \u00a0\n\nestarem\t\n \u00a0 ao\t\n \u00a0 nosso\t\n \u00a0 lado\t\n \u00a0 e\t\n \u00a0 sempre\t\n \u00a0 dispostos\t\n \u00a0 a\t\n \u00a0 nos\t\n \u00a0 ajudar\t\n \u00a0 no\t\n \u00a0 desenvolvimento\t\n \u00a0 de\t\n \u00a0 nossas\t\n \u00a0\n\npesquisas.\t\n \u00a0Voc\u00eas\t\n \u00a0s\u00e3o\t\n \u00a0exemplos\t\n \u00a0a\t\n \u00a0serem\t\n \u00a0seguidos.\t\n \u00a0\n\nAo\t\n \u00a0senhor\t\n \u00a0Camilo\t\n \u00a0Roberto\t\n \u00a0Venancio\t\n \u00a0pela\t\n \u00a0disponibilidade,\t\n \u00a0carinho\t\n \u00a0e\t\n \u00a0aten\u00e7\u00e3o\t\n \u00a0com\t\n \u00a0os\t\n \u00a0\n\nanimais\t\n \u00a0do\t\n \u00a0biot\u00e9rio\t\n \u00a0desta\t\n \u00a0faculdade,\t\n \u00a0assim\t\n \u00a0como\t\n \u00a0o\t\n \u00a0senhor\t\n \u00a0Arnaldo\t\n \u00a0Cezar\t\n \u00a0Dos\t\n \u00a0Santos,\t\n \u00a0que\t\n \u00a0com\t\n \u00a0\n\no\t\n \u00a0mesmo\t\n \u00a0carinho\t\n \u00a0vem\t\n \u00a0tratando\t\n \u00a0dos\t\n \u00a0animais\t\n \u00a0aqui\t\n \u00a0operados\t\n \u00a0sendo\t\n \u00a0de\t\n \u00a0fundamental\t\n \u00a0import\u00e2ncia\t\n \u00a0\n\npara\t\n \u00a0o\t\n \u00a0andamento\t\n \u00a0de\t\n \u00a0nossas\t\n \u00a0pesquisas.\t\n \u00a0Deixo\t\n \u00a0aqui\t\n \u00a0um\t\n \u00a0grande\t\n \u00a0abra\u00e7o.\t\n \u00a0\n\nA\t\n \u00a0Faculdade\t\n \u00a0de\t\n \u00a0Odontologia\t\n \u00a0de\t\n \u00a0Araraquara\t\n \u00a0-\u00ad?\t\n \u00a0UNESP,\t\n \u00a0pela\t\n \u00a0facilita\u00e7\u00e3o\t\n \u00a0na\t\n \u00a0obten\u00e7\u00e3o\t\n \u00a0das\t\n \u00a0\n\nimagens\t\n \u00a0microtomogr\u00e1ficas.\t\n \u00a0\n\nA\t\n \u00a0 Coordena\u00e7\u00e3o\t\n \u00a0 de\t\n \u00a0 Aperfei\u00e7oamento\t\n \u00a0 Pessoal\t\n \u00a0 de\t\n \u00a0 N\u00edvel\t\n \u00a0 Superior\t\n \u00a0 (CAPES),\t\n \u00a0 pela\t\n \u00a0\n\nconcess\u00e3o\t\n \u00a0 da\t\n \u00a0 Bolsa\t\n \u00a0 de\t\n \u00a0 Doutorado\t\n \u00a0 durante\t\n \u00a0 o\t\n \u00a0 curso.\t\n \u00a0 Meus\t\n \u00a0 sinceros\t\n \u00a0 agradecimentos\t\n \u00a0 por\t\n \u00a0\n\npromover\t\n \u00a0o\t\n \u00a0apoio\t\n \u00a0financeiro\t\n \u00a0e\t\n \u00a0com\t\n \u00a0isso,\t\n \u00a0permitir\t\n \u00a0que\t\n \u00a0fosse\t\n \u00a0poss\u00edvel\t\n \u00a0a\t\n \u00a0realiza\u00e7\u00e3o\t\n \u00a0do\t\n \u00a0doutorado.\t\n \u00a0\n\n\t\n \u00a0\n\n\n\n10\t\n \u00a0\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\nAGRADECIMENTOS\t\n \u00a0\n\n\n\n11\t\n \u00a0\n\t\n \u00a0\n\n\t\n \u00a0\n\nAgradecimentos\t\n \u00a0\n\n\u00c0\t\n \u00a0Faculdade\t\n \u00a0de\t\n \u00a0Odontologia\t\n \u00a0de\t\n \u00a0Ara\u00e7atuba\t\n \u00a0\u2013\t\n \u00a0UNESP,\t\n \u00a0na\t\n \u00a0pessoa\t\n \u00a0do\t\n \u00a0diretor\t\n \u00a0Prof.\t\n \u00a0Titular\t\n \u00a0\n\nWilson\t\n \u00a0Roberto\t\n \u00a0Poi\t\n \u00a0pela\t\n \u00a0oportunidade\t\n \u00a0de\t\n \u00a0realiza\u00e7\u00e3o\t\n \u00a0do\t\n \u00a0curso\t\n \u00a0de\t\n \u00a0Doutorado.\t\n \u00a0\t\n \u00a0\n\nAo\t\n \u00a0Coordenador\t\n \u00a0do\t\n \u00a0Programa\t\n \u00a0de\t\n \u00a0P\u00f3s-\u00ad?Gradua\u00e7\u00e3o\t\n \u00a0em\t\n \u00a0Odontologia,\t\n \u00a0da\t\n \u00a0Faculdade\t\n \u00a0de\t\n \u00a0\n\nOdontologia\t\n \u00a0de\t\n \u00a0Ara\u00e7atuba,\t\n \u00a0da\t\n \u00a0Universidade\t\n \u00a0Estadual\t\n \u00a0Paulista\t\n \u00a0\u201cJ\u00falio\t\n \u00a0de\t\n \u00a0Mesquita\t\n \u00a0Filho\u201d\t\n \u00a0Prof.\t\n \u00a0\n\nAdj.\t\n \u00a0Andr\u00e9\t\n \u00a0Luiz\t\n \u00a0Fraga\t\n \u00a0Briso,\t\n \u00a0pela\t\n \u00a0compet\u00eancia\t\n \u00a0e\t\n \u00a0afinco\t\n \u00a0na\t\n \u00a0condu\u00e7\u00e3o\t\n \u00a0da\t\n \u00a0nossa\t\n \u00a0p\u00f3s-\u00ad?gradua\u00e7\u00e3o.\t\n \u00a0\t\n \u00a0\n\nAos\t\n \u00a0 funcion\u00e1rios\t\n \u00a0 da\t\n \u00a0 P\u00f3s-\u00ad?gradua\u00e7\u00e3o\t\n \u00a0 da\t\n \u00a0 Faculdade\t\n \u00a0 de\t\n \u00a0 Odontologia\t\n \u00a0 de\t\n \u00a0 Ara\u00e7atuba\t\n \u00a0 -\u00ad?\t\n \u00a0\n\nUNESP\t\n \u00a0 pela\t\n \u00a0 disponibilidade\t\n \u00a0 e\t\n \u00a0 paci\u00eancia\t\n \u00a0 em\t\n \u00a0 todas\t\n \u00a0 as\t\n \u00a0 etapas\t\n \u00a0 do\t\n \u00a0 doutorado.\t\n \u00a0 Pelo\t\n \u00a0 trabalho\t\n \u00a0\n\nhonesto\t\n \u00a0e\t\n \u00a0sempre\t\n \u00a0\u00e1gil.\t\n \u00a0\n\nAos\t\n \u00a0funcion\u00e1rios\t\n \u00a0da\t\n \u00a0Biblioteca\t\n \u00a0da\t\n \u00a0Faculdade\t\n \u00a0de\t\n \u00a0Odontologia\t\n \u00a0de\t\n \u00a0Ara\u00e7atuba\t\n \u00a0\u2013\t\n \u00a0UNESP\t\n \u00a0\n\npela\t\n \u00a0prontid\u00e3o\t\n \u00a0em\t\n \u00a0nos\t\n \u00a0atender\t\n \u00a0e\t\n \u00a0carinho.\t\n \u00a0\n\nAos\t\n \u00a0 funcion\u00e1rios\t\n \u00a0 do\t\n \u00a0 Departamento\t\n \u00a0 de\t\n \u00a0 Cirurgia\t\n \u00a0 e\t\n \u00a0 Cl\u00ednica\t\n \u00a0 Integrada\t\n \u00a0 (Dirce,\t\n \u00a0 Gilmar,\t\n \u00a0\n\nOdair,\t\n \u00a0Tina,\t\n \u00a0Paulo\t\n \u00a0Grat\u00e3o,\t\n \u00a0Renato\t\n \u00a0e\t\n \u00a0Joilson).\t\n \u00a0Muito\t\n \u00a0obrigado\t\n \u00a0pelo\t\n \u00a0carinho\t\n \u00a0e\t\n \u00a0respeito.\t\n \u00a0\nAos\t\n \u00a0 colegas\t\n \u00a0 da\t\n \u00a0 p\u00f3s-\u00ad?gradua\u00e7\u00e3o\t\n \u00a0 da\t\n \u00a0 \u00e1rea\t\n \u00a0 de\t\n \u00a0 Cirurgia\t\n \u00a0 e\t\n \u00a0 Traumatologia\t\n \u00a0\n\nBucomaxilofacial.\t\n \u00a0Tenho\t\n \u00a0aprendido\t\n \u00a0a\t\n \u00a0cada\t\n \u00a0momento\t\n \u00a0com\t\n \u00a0cada\t\n \u00a0um\t\n \u00a0de\t\n \u00a0voc\u00eas.\t\n \u00a0Obrigado\t\n \u00a0pelo\t\n \u00a0\n\naux\u00edlio\t\n \u00a0constante\t\n \u00a0na\t\n \u00a0minha\t\n \u00a0vida\t\n \u00a0e\t\n \u00a0na\t\n \u00a0p\u00f3s-\u00ad?gradua\u00e7\u00e3o.\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\n\n12\t\n \u00a0\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\nLISTAS\t\n \u00a0E\t\n \u00a0SUM\u00c1RIO\t\n \u00a0\n\n\n\n13\t\n \u00a0\n\t\n \u00a0\n\n\t\n \u00a0\n\nLista\t\n \u00a0de\t\n \u00a0Figuras\t\n \u00a0\n\t\n \u00a0\n\nFigura\t\n \u00a01\t\n \u00a0\u2013\t\n \u00a0Imagens\t\n \u00a0microtomogr\u00e1ficas\t\n \u00a0com\t\n \u00a0transpar\u00eancia\t\n \u00a0da\t\n \u00a0bi\u00f3psia\t\n \u00a0do\t\n \u00a0grupo\t\n \u00a0GSA\t\n \u00a0(A)\t\n \u00a0e\t\n \u00a0GAS\t\n \u00a0\n(B)\t\n \u00a0em\t\n \u00a0vista\t\n \u00a0frontal\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0\n\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 34\t\n \u00a0\n\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0\nFigura\t\n \u00a02.\t\n \u00a0Imagens\t\n \u00a0microtomogr\u00e1ficas\t\n \u00a0sem\t\n \u00a0transpar\u00eancia\t\n \u00a0da\t\n \u00a0bi\u00f3psia\t\n \u00a0do\t\n \u00a0grupo\t\n \u00a0GSA\t\n \u00a0(A)\t\n \u00a0e\t\n \u00a0GAS\t\n \u00a0(B)\t\n \u00a0\nem\t\n \u00a0vista\t\n \u00a0frontal\t\n \u00a0\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 35\t\n \u00a0\n\t\n \u00a0 \t\n \u00a0\nFigura\t\n \u00a03\t\n \u00a0\u2013Representa\u00e7\u00e3o\t\n \u00a0dos\t\n \u00a0valores\t\n \u00a0m\u00e9dios\t\n \u00a0de\t\n \u00a0BV\t\n \u00a0entre\t\n \u00a0os\t\n \u00a0grupos\t\n \u00a0experimentais\t\n \u00a0GSA\t\n \u00a0e\t\n \u00a0GAS.\t\n \u00a0\n\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 36\t\n \u00a0\n\n\t\n \u00a0\nFigura\t\n \u00a04\t\n \u00a0\u2013\t\n \u00a0Representa\u00e7\u00e3o\t\n \u00a0dos\t\n \u00a0valores\t\n \u00a0m\u00e9dios\t\n \u00a0de\t\n \u00a0BV/TV\t\n \u00a0entre\t\n \u00a0os\t\n \u00a0grupos\t\n \u00a0experimentais\t\n \u00a0GSA\t\n \u00a0e\t\n \u00a0\nGAS.\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 36\t\n \u00a0\n\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0\n\nFigura\t\n \u00a05\t\n \u00a0-\u00ad?\t\n \u00a0Representa\u00e7\u00e3o\t\n \u00a0dos\t\n \u00a0valores\t\n \u00a0m\u00e9dios\t\n \u00a0de\t\n \u00a0Tb.Th\t\n \u00a0entre\t\n \u00a0os\t\n \u00a0grupos\t\n \u00a0experimentais\t\n \u00a0GSA\t\n \u00a0e\t\n \u00a0\nGAS.\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 37\t\n \u00a0\n\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0\n\nFigura\t\n \u00a06\t\n \u00a0-\u00ad?\t\n \u00a0Representa\u00e7\u00e3o\t\n \u00a0dos\t\n \u00a0valores\t\n \u00a0m\u00e9dios\t\n \u00a0de\t\n \u00a0Tb.N\t\n \u00a0entre\t\n \u00a0os\t\n \u00a0grupos\t\n \u00a0experimentais\t\n \u00a0GSA\t\n \u00a0e\t\n \u00a0\nGAS.\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0\n\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0 37\t\n \u00a0\n\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0\n\nFigura\t\n \u00a07\t\n \u00a0-\u00ad?\t\n \u00a0Representa\u00e7\u00e3o\t\n \u00a0dos\t\n \u00a0valores\t\n \u00a0m\u00e9dios\t\n \u00a0de\t\n \u00a0Tb.Sp\t\n \u00a0entre\t\n \u00a0os\t\n \u00a0grupos\t\n \u00a0experimentais\t\n \u00a0GSA\t\n \u00a0e\t\n \u00a0\nGAS.\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 38\t\n \u00a0\n\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0\nFigura\t\n \u00a08\t\n \u00a0-\u00ad?\t\n \u00a0Representa\u00e7\u00e3o\t\n \u00a0dos\t\n \u00a0valores\t\n \u00a0m\u00e9dios\t\n \u00a0de\t\n \u00a0Potot\t\n \u00a0entre\t\n \u00a0os\t\n \u00a0grupos\t\n \u00a0experimentais\t\n \u00a0GSA\t\n \u00a0e\t\n \u00a0\nGAS.\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 38\t\n \u00a0\n\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0\n\nFigura\t\n \u00a09\t\n \u00a0-\u00ad?\t\n \u00a0Imagens\t\n \u00a0histol\u00f3gicas\t\n \u00a0da\t\n \u00a0bi\u00f3psia\t\n \u00a0do\t\n \u00a0grupo\t\n \u00a0GSA\t\n \u00a0(A)\t\n \u00a0e\t\n \u00a0GAS\t\n \u00a0(B)\t\n \u00a0no\t\n \u00a0aumento\t\n \u00a0de\t\n \u00a06,3X.\t\n \u00a0\n\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 40\t\n \u00a0\n\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0\n\nFigura\t\n \u00a010\t\n \u00a0-\u00ad?\t\n \u00a0Imagens\t\n \u00a0histol\u00f3gicas\t\n \u00a0das\t\n \u00a0bi\u00f3psia\t\n \u00a0do\t\n \u00a0grupo\t\n \u00a0GAS\t\n \u00a0(A)\t\n \u00a0e\t\n \u00a0GSA\t\n \u00a0(B)\t\n \u00a0em\t\n \u00a0aumento\t\n \u00a0de\t\n \u00a0\n40X.\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0\n\t\n \u00a0 \t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a040\t\n \u00a0\n\t\n \u00a0\nFigura\t\n \u00a011\t\n \u00a0-\u00ad?\t\n \u00a0Imagens\t\n \u00a0imunoistoqu\u00edmicasdos\t\n \u00a0grupo\t\n \u00a0GSA\t\n \u00a0e\t\n \u00a0GAS\t\n \u00a0com\t\n \u00a0imunomarca\u00e7\u00f5es\t\n \u00a0de\t\n \u00a0Runx2,\t\n \u00a0\nOP\t\n \u00a0e\t\n \u00a0OC\t\n \u00a0no\t\n \u00a0aumento\t\n \u00a0de\t\n \u00a040X.\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 43\t\n \u00a0\n\t\n \u00a0 \t\n \u00a0\n\n\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0\n\n\n\n14\t\n \u00a0\n\nLista\t\n \u00a0de\t\n \u00a0Tabelas\t\n \u00a0\n\nTabela\t\n \u00a01\t\n \u00a0\u2013\t\n \u00a0Valores\t\n \u00a0m\u00e9dios,\t\n \u00a0desvio\t\n \u00a0padr\u00e3o\t\n \u00a0e\t\n \u00a0do\t\n \u00a0coeficiente\t\n \u00a0estat\u00edstico\t\n \u00a0(p)\t\n \u00a0para\t\n \u00a0os\t\n \u00a0par\u00e2metros\t\n \u00a0\nvolum\u00e9tricos\t\n \u00a0(BV,\t\n \u00a0BV/TV,\t\n \u00a0Tb.Th,\t\n \u00a0Tb.N,\t\n \u00a0Tb.\t\n \u00a0Sp\t\n \u00a0e\t\n \u00a0Po\t\n \u00a0(tot),\t\n \u00a0na\t\n \u00a0compara\u00e7\u00e3o\t\n \u00a0entre\t\n \u00a0os\t\n \u00a0grupos\t\n \u00a0GSA\t\n \u00a0e\t\n \u00a0\nGAS.\t\n \u00a0\n\n34\t\n \u00a0\n\nTabela\t\n \u00a02\t\n \u00a0\u2013\t\n \u00a0Representa\u00e7\u00e3o\t\n \u00a0dos\t\n \u00a0escores\t\n \u00a0mais\t\n \u00a0frequentes\t\n \u00a0durante\t\n \u00a0a\t\n \u00a0an\u00e1lise\t\n \u00a0qualitativa\t\n \u00a0ordinal\t\n \u00a0da\t\n \u00a0\nimunoistoqu\u00edmica\t\n \u00a0das\t\n \u00a0prote\u00ednas\t\n \u00a0Runx2,\t\n \u00a0OP\t\n \u00a0e\t\n \u00a0OP,\t\n \u00a0para\t\n \u00a0os\t\n \u00a0grupos\t\n \u00a0GSA\t\n \u00a0e\t\n \u00a0GAS.\t\n \u00a0\n\n41\t\n \u00a0\n\n\n\n15\t\n \u00a0\n\nLista\t\n \u00a0de\t\n \u00a0Abreviaturas\t\n \u00a0\n\nmm\t\n \u00a0 =\t\n \u00a0Unidade\t\n \u00a0de\t\n \u00a0medida\t\n \u00a0mil\u00edmetros\t\n \u00a0\n\nHAS\t\n \u00a0 =\t\n \u00a0Hipertens\u00e3o\t\n \u00a0arterial\t\n \u00a0sist\u00eamica\t\n \u00a0\n\nSRAA\t\n \u00a0 =\t\n \u00a0Sistema\t\n \u00a0renina-\u00ad?angiotensina-\u00ad?aldoesterona\t\n \u00a0\n\nAng\t\n \u00a0II\t\n \u00a0 =\t\n \u00a0Angiotensina\t\n \u00a0II\t\n \u00a0\n\nECA\t\n \u00a0 =\t\n \u00a0Enzima\t\n \u00a0conversora\t\n \u00a0de\t\n \u00a0angiotensina\t\n \u00a0\n\nRunx2\t\n \u00a0 =\t\n \u00a0Fator\t\n \u00a02\t\n \u00a0de\t\n \u00a0transcri\u00e7\u00e3o\t\n \u00a0relacionado\t\n \u00a0a\t\n \u00a0Runt\t\n \u00a0\n\nOP\t\n \u00a0 =\t\n \u00a0Osteopontina\t\n \u00a0\n\nOC\t\n \u00a0 =\t\n \u00a0Osteocalcina\t\n \u00a0\n\n?\t\n \u00a0 =\t\n \u00a0Coeficiente\t\n \u00a0estat\u00edstico\t\n \u00a0de\t\n \u00a0confiabilidade\t\n \u00a0\n\np\t\n \u00a0 =\t\n \u00a0N\u00edvel\t\n \u00a0de\t\n \u00a0signific\u00e2ncia\t\n \u00a0estat\u00edstica\t\n \u00a0(p<0,05)\t\n \u00a0\n\nmg/kg\t\n \u00a0 =\t\n \u00a0Unidade\t\n \u00a0de\t\n \u00a0medida\t\n \u00a0miligramas\t\n \u00a0por\t\n \u00a0quilograma\t\n \u00a0\n\nIM\t\n \u00a0 =\t\n \u00a0Via\t\n \u00a0de\t\n \u00a0administra\u00e7\u00e3o\t\n \u00a0intramuscular\t\n \u00a0\n\n%\t\n \u00a0 =\t\n \u00a0Percentual\t\n \u00a0\n\nRpm\t\n \u00a0 =\t\n \u00a0Rota\u00e7\u00e3o\t\n \u00a0por\t\n \u00a0minuto\t\n \u00a0\n\nml =\t\n \u00a0Unidade\t\n \u00a0de\t\n \u00a0volume\t\n \u00a0mililitro\t\n \u00a0\n\n\n\n16\t\n \u00a0\n\t\n \u00a0\n\n\t\n \u00a0\n\nEDTA\t\n \u00a0 =\t\n \u00a0\u00c1cido\t\n \u00a0etilenodiamino\t\n \u00a0tetra-\u00ad?ac\u00e9tico\t\n \u00a0\t\n \u00a0\n\nHE\t\n \u00a0 =\t\n \u00a0Corantes\t\n \u00a0Hematoxilina\t\n \u00a0e\t\n \u00a0Eosina\t\n \u00a0\n\n\u00b5m\u00b2\t\n \u00a0 =\t\n \u00a0Unidade\t\n \u00a0de\t\n \u00a0medida\t\n \u00a0micrometros\t\n \u00a0ao\t\n \u00a0quadrado\t\n \u00a0\n\nBV\t\n \u00a0 =\t\n \u00a0Volume\t\n \u00a0\u00f3sseo\t\n \u00a0\n\nBV/TV\t\n \u00a0 =Percentual\t\n \u00a0de\t\n \u00a0volume\t\n \u00a0\u00f3sseo\t\n \u00a0\n\nTb.Th\t\n \u00a0 =\t\n \u00a0Espessura\t\n \u00a0trabecular\t\n \u00a0\n\nTb.N\t\n \u00a0 =\t\n \u00a0N\u00famero\t\n \u00a0de\t\n \u00a0trab\u00e9culas\t\n \u00a0\n\nTb.S\t\n \u00a0 =\t\n \u00a0Separa\u00e7\u00e3o\t\n \u00a0trabecular\t\n \u00a0\n\nPotot\t\n \u00a0 =\t\n \u00a0Porosidade\t\n \u00a0total\t\n \u00a0\n\nGSA\t\n \u00a0 =\t\n \u00a0Grupo\t\n \u00a0sem\t\n \u00a0altera\u00e7\u00e3o\t\n \u00a0\n\nGAS\t\n \u00a0 =\t\n \u00a0Grupo\t\n \u00a0altera\u00e7\u00e3o\t\n \u00a0sist\u00eamica\t\n \u00a0\n\nASA\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0=\t\n \u00a0Articulador\t\n \u00a0Semi-\u00ad?ajust\u00e1vel\t\n \u00a0\n\nINR\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0=\t\n \u00a0Raz\u00e3o\t\n \u00a0normalizada\t\n \u00a0internacional\t\n \u00a0 \t\n \u00a0\n\nN.cm\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0\t\n \u00a0=\t\n \u00a0Newtons\t\n \u00a0por\t\n \u00a0cent\u00edmetos\t\n \u00a0\n\n\n\n17\t\n \u00a0\n\t\n \u00a0\n\n\t\n \u00a0\n\nSum\u00e1rio\t\n \u00a0\n\nAn\u00e1lise\t\n \u00a0 histol\u00f3gica,\t\n \u00a0 imunoistoqu\u00edmica\t\n \u00a0 e\t\n \u00a0 morfom\u00e9trica\t\n \u00a0 de\t\n \u00a0 bi\u00f3psias\t\n \u00a0 de\t\n \u00a0 tecido\t\n \u00a0 \u00f3sseo\t\n \u00a0 de\t\n \u00a0\n\npacientes\t\n \u00a0hipertensos\t\n \u00a0compensados\t\n \u00a0\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0\n\nResumo\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 20\t\n \u00a0\n\nAbstract\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 22\t\n \u00a0\n\nIntrodu\u00e7\u00e3o\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 24\t\n \u00a0\n\nMaterial\t\n \u00a0e\t\n \u00a0M\u00e9todos\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 27\t\n \u00a0\n\nResultados\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 33\t\n \u00a0\n\nDiscuss\u00e3o\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 44\t\n \u00a0\n\nRefer\u00eancias\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 49\t\n \u00a0\n\nAnexos\t\n \u00a0\t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 \t\n \u00a0 53\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\nAn\u00e1lise\t\n \u00a0 histol\u00f3gica,\t\n \u00a0 imunoistoqu\u00edmica\t\n \u00a0 e\t\n \u00a0 morfom\u00e9trica\t\n \u00a0 de\t\n \u00a0\n\nbi\u00f3psias\t\n \u00a0 de\t\n \u00a0 tecido\t\n \u00a0 \u00f3sseo\t\n \u00a0 de\t\n \u00a0 pacientes\t\n \u00a0 hipertensos\t\n \u00a0\n\ncompensados\t\n \u00a0\t\n \u00a0 \t\n \u00a0\n*Este\t\n \u00a0 trabalho\t\n \u00a0 foi\t\n \u00a0 formatado\t\n \u00a0 de\t\n \u00a0 acordo\t\n \u00a0 com\t\n \u00a0 as\t\n \u00a0 normas\t\n \u00a0 do\t\n \u00a0 peri\u00f3dico\t\n \u00a0 Clinical\t\n \u00a0 Oral\t\n \u00a0 Implants\t\n \u00a0\n\nResearch\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\n\n19\t\n \u00a0\n\t\n \u00a0\n\n\t\n \u00a0\n\nFabris\t\n \u00a0ALS.\t\n \u00a0An\u00e1lise\t\n \u00a0histol\u00f3gica,\t\n \u00a0imunoistoqu\u00edmica\t\n \u00a0e\t\n \u00a0morfom\u00e9trica\t\n \u00a0de\t\n \u00a0bi\u00f3psias\t\n \u00a0de\t\n \u00a0tecido\t\n \u00a0\n\n\u00f3sseo\t\n \u00a0de\t\n \u00a0pacientes\t\n \u00a0hipertensos\t\n \u00a0compensados\t\n \u00a0\t\n \u00a0 \t\n \u00a0[Tese].\t\n \u00a0 Ara\u00e7atuba:\t\n \u00a0 Faculdade\t\n \u00a0 de\t\n \u00a0\n\nOdontologia\t\n \u00a0da\t\n \u00a0Universidade\t\n \u00a0Estadual\t\n \u00a0Paulista;\t\n \u00a02016.\t\n \u00a0\n\n\t\n \u00a0\n\nResumo\t\n \u00a0\n\nObjetivo:\t\n \u00a0 O\t\n \u00a0 presente\t\n \u00a0 estudo\t\n \u00a0 objetivou\t\n \u00a0 avaliar\t\n \u00a0 as\t\n \u00a0 caracter\u00edsticas\t\n \u00a0\n\nmorfom\u00e9ticas,\t\n \u00a0histol\u00f3gicas\t\n \u00a0e\t\n \u00a0imunoistoqu\u00edmicas\t\n \u00a0do\t\n \u00a0tecido\t\n \u00a0\u00f3sseo\t\n \u00a0coletado\t\n \u00a0de\t\n \u00a0pacientes\t\n \u00a0\n\nportadores\t\n \u00a0de\t\n \u00a0hipertens\u00e3o\t\n \u00a0arterial\t\n \u00a0sist\u00eamica\t\n \u00a0compensada\t\n \u00a0pelo\t\n \u00a0uso\t\n \u00a0de\t\n \u00a0medicamentos\t\n \u00a0\n\nantagonistas\t\n \u00a0do\t\n \u00a0sistema\t\n \u00a0renina-\u00ad?angiotensina-\u00ad?aldoesterona\t\n \u00a0(SRAA).\t\n \u00a0\t\n \u00a0\n\nMateriais\t\n \u00a0e\t\n \u00a0M\u00e9todos:\t\n \u00a0Trinta\t\n \u00a0pacientes\t\n \u00a0com\t\n \u00a0indica\u00e7\u00e3o\t\n \u00a0para\t\n \u00a0reabilita\u00e7\u00e3o\t\n \u00a0por\t\n \u00a0\n\nmeio\t\n \u00a0 de\t\n \u00a0 implantes\t\n \u00a0 instalados\t\n \u00a0 na\t\n \u00a0 regi\u00e3o\t\n \u00a0 posterior\t\n \u00a0 de\t\n \u00a0 mand\u00edbula\t\n \u00a0 foram\t\n \u00a0 divididos\t\n \u00a0 em\t\n \u00a0\n\ndois\t\n \u00a0grupos,\t\n \u00a0seguindo\t\n \u00a0os\t\n \u00a0crit\u00e9rios\t\n \u00a0de\t\n \u00a0inclus\u00e3o\t\n \u00a0e\t\n \u00a0exclus\u00e3o\t\n \u00a0previamente\t\n \u00a0estabelecidos.\t\n \u00a0O\t\n \u00a0\n\nprimeiro\t\n \u00a0 grupo\t\n \u00a0 n\u00e3o\t\n \u00a0 apresentava\t\n \u00a0 altera\u00e7\u00f5es\t\n \u00a0 sist\u00eamicas\t\n \u00a0 (GSA)\t\n \u00a0 e\t\n \u00a0 n\u00e3o\t\n \u00a0 fazia\t\n \u00a0 uso\t\n \u00a0 de\t\n \u00a0\n\nqualquer\t\n \u00a0 medica\u00e7\u00e3o\t\n \u00a0 e,\t\n \u00a0 o\t\n \u00a0 segundo\t\n \u00a0 grupo\t\n \u00a0 foi\t\n \u00a0 composto\t\n \u00a0 por\t\n \u00a0 pacientes\t\n \u00a0 hipertensos\t\n \u00a0\n\ndiagnosticados\t\n \u00a0e\t\n \u00a0medicados\t\n \u00a0por\t\n \u00a0antagonistas\t\n \u00a0do\t\n \u00a0SRAA\t\n \u00a0(GAS).\t\n \u00a0Durante\t\n \u00a0o\t\n \u00a0procedimento\t\n \u00a0\n\ncir\u00fargico\t\n \u00a0 para\t\n \u00a0 instala\u00e7\u00e3o\t\n \u00a0 dos\t\n \u00a0 implantes\t\n \u00a0 osseointegr\u00e1veis\t\n \u00a0 com\t\n \u00a0 superf\u00edcie\t\n \u00a0 texturizada,\t\n \u00a0\n\nforam\t\n \u00a0coletados\t\n \u00a0blocos\t\n \u00a0\u00f3sseos\t\n \u00a0por\t\n \u00a0meio\t\n \u00a0de\t\n \u00a0bi\u00f3psia\t\n \u00a0com\t\n \u00a0broca\t\n \u00a0trefina\t\n \u00a0de\t\n \u00a03,0mm\t\n \u00a0de\t\n \u00a0\n\ndi\u00e2metro\t\n \u00a0 nos\t\n \u00a0 locais\t\n \u00a0 de\t\n \u00a0 instala\u00e7\u00e3o\t\n \u00a0 dos\t\n \u00a0 implantes.\t\n \u00a0 As\t\n \u00a0 bi\u00f3psias\t\n \u00a0 coletadas\t\n \u00a0 foram\t\n \u00a0\n\nseparadas\t\n \u00a0para\t\n \u00a0avalia\u00e7\u00e3o\t\n \u00a0por\t\n \u00a0microtomografia\t\n \u00a0computadorizada,\t\n \u00a0sendo\t\n \u00a0avaliados\t\n \u00a0os\t\n \u00a0\n\nseguintes\t\n \u00a0par\u00e2metros:\t\n \u00a0 \t\n \u00a0volume\t\n \u00a0\u00f3sseo\t\n \u00a0(BV/TV),\t\n \u00a0percentual\t\n \u00a0de\t\n \u00a0volume\t\n \u00a0\u00f3sseo\t\n \u00a0(BV/TV),\t\n \u00a0\n\nespessura\t\n \u00a0 de\t\n \u00a0 trab\u00e9culas\t\n \u00a0 (Tb.Th),\t\n \u00a0 n\u00famero\t\n \u00a0 de\t\n \u00a0 trab\u00e9culas\t\n \u00a0 (Tb.N),\t\n \u00a0 separa\u00e7\u00e3o\t\n \u00a0 entre\t\n \u00a0 as\t\n \u00a0\n\ntrab\u00e9culas\t\n \u00a0(Tb.S)\t\n \u00a0e\t\n \u00a0porosidade\t\n \u00a0total\t\n \u00a0(Po-\u00ad?tot).\t\n \u00a0Tamb\u00e9m\t\n \u00a0foi\t\n \u00a0realizada\t\n \u00a0a\t\n \u00a0an\u00e1lise\t\n \u00a0dos\t\n \u00a0cortes\t\n \u00a0\n\nhistol\u00f3gicos\t\n \u00a0 corados\t\n \u00a0 por\t\n \u00a0 hematoxilina\t\n \u00a0 e\t\n \u00a0 eosina,\t\n \u00a0 bem\t\n \u00a0 como\t\n \u00a0 a\t\n \u00a0 avalia\u00e7\u00e3o\t\n \u00a0\n\n\n\n20\t\n \u00a0\n\t\n \u00a0\n\n\t\n \u00a0\n\nimunoistoqu\u00edmica\t\n \u00a0de\t\n \u00a0prote\u00ednas\t\n \u00a0que\t\n \u00a0caracterizam\t\n \u00a0as\t\n \u00a0c\u00e9lulas\t\n \u00a0da\t\n \u00a0linhagem\t\n \u00a0osteobl\u00e1stica:\t\n \u00a0\n\nRunx2,\t\n \u00a0Osteopontina\t\n \u00a0e\t\n \u00a0Osteocalcina\t\n \u00a0\n\n\t\n \u00a0 Resultados:\t\n \u00a0Para\t\n \u00a0todos\t\n \u00a0os\t\n \u00a0par\u00e2metros\t\n \u00a0analisados\t\n \u00a0(BV,\t\n \u00a0BV/TV,\t\n \u00a0Tb.Th,\t\n \u00a0Tb.N,\t\n \u00a0Tb.S\t\n \u00a0\n\ne\t\n \u00a0Po-\u00ad?tot),\t\n \u00a0houve\t\n \u00a0similaridade\t\n \u00a0na\t\n \u00a0compara\u00e7\u00e3o\t\n \u00a0entre\t\n \u00a0os\t\n \u00a0grupos\t\n \u00a0GAS\t\n \u00a0e\t\n \u00a0GSA\t\n \u00a0(p<0,05,\t\n \u00a0teste\t\n \u00a0\n\nt).\t\n \u00a0 As\t\n \u00a0 imunomarca\u00e7\u00f5es\t\n \u00a0 para\t\n \u00a0 osteopontina\t\n \u00a0 e\t\n \u00a0 osteocalcina\t\n \u00a0 mostraram-\u00ad?se\t\n \u00a0 semelhantes\t\n \u00a0\n\nnos\t\n \u00a0dois\t\n \u00a0grupos.\t\n \u00a0Vale\t\n \u00a0destacar\t\n \u00a0importante\t\n \u00a0marca\u00e7\u00e3o\t\n \u00a0observada\t\n \u00a0no\t\n \u00a0grupo\t\n \u00a0GAS\t\n \u00a0para\t\n \u00a0o\t\n \u00a0\n\nfator\t\n \u00a0de\t\n \u00a0transcri\u00e7\u00e3o\t\n \u00a0Runt\t\n \u00a02\t\n \u00a0(Runx2),\t\n \u00a0em\t\n \u00a0compara\u00e7\u00e3o\t\n \u00a0a\t\n \u00a0marca\u00e7\u00e3o\t\n \u00a0da\t\n \u00a0mesma\t\n \u00a0prote\u00edna\t\n \u00a0no\t\n \u00a0\n\ngrupo\t\n \u00a0 GSA.\t\n \u00a0 Al\u00e9m\t\n \u00a0 disso,\t\n \u00a0 a\t\n \u00a0 biologia\t\n \u00a0 do\t\n \u00a0 tecido\t\n \u00a0 \u00f3sseo\t\n \u00a0 do\t\n \u00a0 ponto\t\n \u00a0 de\t\n \u00a0 vista\t\n \u00a0 histol\u00f3gico\t\n \u00a0 foi\t\n \u00a0\n\nsemelhante\t\n \u00a0nos\t\n \u00a0dois\t\n \u00a0grupos.\t\n \u00a0\n\nConclus\u00f5es:\t\n \u00a0Foi\t\n \u00a0poss\u00edvel\t\n \u00a0concluir\t\n \u00a0que\t\n \u00a0 indiv\u00edduos\t\n \u00a0hipertensos\t\n \u00a0tratados\t\n \u00a0com\t\n \u00a0\n\nantagonistas\t\n \u00a0 do\t\n \u00a0 SRAA\t\n \u00a0 apresentam\t\n \u00a0 grande\t\n \u00a0 similaridade\t\n \u00a0 \u00f3ssea\t\n \u00a0 microestrutural\t\n \u00a0 e\t\n \u00a0\n\ntamb\u00e9m\t\n \u00a0celular/prot\u00e9ica\t\n \u00a0aos\t\n \u00a0indiv\u00edduos\t\n \u00a0normotensos.\t\n \u00a0\n\nPalavras\t\n \u00a0chaves:\t\n \u00a0hipertens\u00e3o,\t\n \u00a0implantes\t\n \u00a0dent\u00e1rios,\t\n \u00a0osso\t\n \u00a0e\t\n \u00a0ossos.\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\n\n\n\n21\t\n \u00a0\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0 Fabris\t\n \u00a0ALS.\t\n \u00a0Histological,\t\n \u00a0molecular\t\n \u00a0and\t\n \u00a0morphometric\t\n \u00a0analysis\t\n \u00a0of\t\n \u00a0\t\n \u00a0bone\t\n \u00a0tissue\t\n \u00a0biopsies\t\n \u00a0\n\nin\t\n \u00a0 compensated\t\n \u00a0 hypertensive\t\n \u00a0 patients\t\n \u00a0 [Thesis].\t\n \u00a0 Ara\u00e7atuba:\t\n \u00a0 UNESP\t\n \u00a0 -\u00ad?\t\n \u00a0 S\u00e3o\t\n \u00a0 Paulo\t\n \u00a0 State\t\n \u00a0\n\nUniversity;\t\n \u00a02016.\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0 Abstract\t\n \u00a0\n\n\t\n \u00a0 Objectives:\t\n \u00a0This\t\n \u00a0study\t\n \u00a0aimed\t\n \u00a0to\t\n \u00a0evaluate\t\n \u00a0the\t\n \u00a0morphometric\t\n \u00a0characteristics,\t\n \u00a0\n\nhistological\t\n \u00a0 and\t\n \u00a0 immunohistochemical\t\n \u00a0 bone\t\n \u00a0 tissue\t\n \u00a0 collected\t\n \u00a0 from\t\n \u00a0 patients\t\n \u00a0 with\t\n \u00a0\n\nhypertension\t\n \u00a0offset\t\n \u00a0by\t\n \u00a0the\t\n \u00a0use\t\n \u00a0of\t\n \u00a0drugs\t\n \u00a0antagonists\t\n \u00a0of\t\n \u00a0the\t\n \u00a0renin\t\n \u00a0angiotensin\t\n \u00a0system.\t\n \u00a0\n\n\t\n \u00a0 Material\t\n \u00a0and\t\n \u00a0Methods:\t\n \u00a030\t\n \u00a0patients\t\n \u00a0referred\t\n \u00a0for\t\n \u00a0rehabilitation\t\n \u00a0with\t\n \u00a0implants\t\n \u00a0\n\nplaced\t\n \u00a0in\t\n \u00a0the\t\n \u00a0posterior\t\n \u00a0mandible\t\n \u00a0were\t\n \u00a0divided\t\n \u00a0into\t\n \u00a0two\t\n \u00a0groups,\t\n \u00a0following\t\n \u00a0the\t\n \u00a0criteria\t\n \u00a0of\t\n \u00a0\n\ninclusion\t\n \u00a0 and\t\n \u00a0 exclusion\t\n \u00a0 previously\t\n \u00a0 established.\t\n \u00a0 The\t\n \u00a0 first\t\n \u00a0 group\t\n \u00a0 showed\t\n \u00a0 no\t\n \u00a0 systemic\t\n \u00a0\n\nchanges\t\n \u00a0(GSA)\t\n \u00a0and\t\n \u00a0did\t\n \u00a0not\t\n \u00a0use\t\n \u00a0any\t\n \u00a0medication\t\n \u00a0and\t\n \u00a0the\t\n \u00a0second\t\n \u00a0group\t\n \u00a0was\t\n \u00a0composed\t\n \u00a0of\t\n \u00a0\n\ndiagnosed\t\n \u00a0 hypertensive\t\n \u00a0 patients\t\n \u00a0 treated\t\n \u00a0 by\t\n \u00a0 RAAS\t\n \u00a0 (GAS)\t\n \u00a0 antagonists.\t\n \u00a0 During\t\n \u00a0 the\t\n \u00a0\n\nprocedure\t\n \u00a0for\t\n \u00a0installation\t\n \u00a0of\t\n \u00a0dental\t\n \u00a0implants\t\n \u00a0with\t\n \u00a0textured\t\n \u00a0surface,\t\n \u00a0they\t\n \u00a0were\t\n \u00a0collected\t\n \u00a0\n\nbone\t\n \u00a0blocks\t\n \u00a0through\t\n \u00a0biopsy\t\n \u00a0trephine\t\n \u00a0drill\t\n \u00a03.0mm\t\n \u00a0diameter\t\n \u00a0implants\t\n \u00a0in\t\n \u00a0the\t\n \u00a0installation\t\n \u00a0\n\nsites.\t\n \u00a0The\t\n \u00a0collected\t\n \u00a0biopsies\t\n \u00a0were\t\n \u00a0separated\t\n \u00a0for\t\n \u00a0evaluation\t\n \u00a0by\t\n \u00a0microtomography,\t\n \u00a0being\t\n \u00a0\n\nevaluated\t\n \u00a0 the\t\n \u00a0 following\t\n \u00a0 parameters:\t\n \u00a0 bone\t\n \u00a0 volume\t\n \u00a0 (BV\t\n \u00a0 /\t\n \u00a0 TV),\t\n \u00a0 trabecular\t\n \u00a0 thickness\t\n \u00a0\n\n(Tb.Th),\t\n \u00a0 trabecular\t\n \u00a0 number\t\n \u00a0 (Tb.N),\t\n \u00a0 separation\t\n \u00a0 of\t\n \u00a0 the\t\n \u00a0 trabecular\t\n \u00a0 (Tb.S)\t\n \u00a0 and\t\n \u00a0 total\t\n \u00a0\n\nporosity\t\n \u00a0 (Po-\u00ad?tot).\t\n \u00a0 Also\t\n \u00a0 the\t\n \u00a0 analysis\t\n \u00a0 of\t\n \u00a0 histological\t\n \u00a0 sections\t\n \u00a0 stained\t\n \u00a0 with\t\n \u00a0 hematoxylin\t\n \u00a0\n\nand\t\n \u00a0eosin\t\n \u00a0staining\t\n \u00a0was\t\n \u00a0performed\t\n \u00a0as\t\n \u00a0well\t\n \u00a0as\t\n \u00a0the\t\n \u00a0immunohistochemical\t\n \u00a0evaluation\t\n \u00a0of\t\n \u00a0\n\nproteins\t\n \u00a0 that\t\n \u00a0 characterize\t\n \u00a0 the\t\n \u00a0 cells\t\n \u00a0 of\t\n \u00a0 osteoblast\t\n \u00a0 lineage:\t\n \u00a0 Runx2,\t\n \u00a0 osteopontin\t\n \u00a0 and\t\n \u00a0\n\nosteocalcin\t\n \u00a0\n\n\n\n22\t\n \u00a0\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0 Results:\t\n \u00a0For\t\n \u00a0all\t\n \u00a0parameters\t\n \u00a0(BV,\t\n \u00a0BV\t\n \u00a0/\t\n \u00a0TV,\t\n \u00a0Tb.Th,\t\n \u00a0Tb.N,\t\n \u00a0Tb.S\t\n \u00a0and\t\n \u00a0E-\u00ad?tot)\t\n \u00a0were\t\n \u00a0\n\nsimilar\t\n \u00a0in\t\n \u00a0the\t\n \u00a0comparison\t\n \u00a0between\t\n \u00a0GAS\t\n \u00a0and\t\n \u00a0GSA\t\n \u00a0(p>\t\n \u00a00.05,\t\n \u00a0t\t\n \u00a0test).\t\n \u00a0The\t\n \u00a0biology\t\n \u00a0of\t\n \u00a0bone\t\n \u00a0\n\ntissue\t\n \u00a0to\t\n \u00a0analyze\t\n \u00a0by\t\n \u00a0immunohistochemistry\t\n \u00a0presented\t\n \u00a0similar\t\n \u00a0results\t\n \u00a0in\t\n \u00a0both\t\n \u00a0groups,\t\n \u00a0\n\nwith\t\n \u00a0markings\t\n \u00a0scores\t\n \u00a0in\t\n \u00a0ordinal\t\n \u00a0qualitative\t\n \u00a0analysis\t\n \u00a0for\t\n \u00a0transcription\t\n \u00a0factor\t\n \u00a0related\t\n \u00a0to\t\n \u00a0\n\nRunt\t\n \u00a0 2\t\n \u00a0 (Runx2)\t\n \u00a0 -\u00ad?\t\n \u00a0 GSA\t\n \u00a0 (light)\t\n \u00a0 and\t\n \u00a0 GAS\t\n \u00a0 (moderate),\t\n \u00a0 osteopontin\t\n \u00a0 (OP)\t\n \u00a0 -\u00ad?\t\n \u00a0 GSA\t\n \u00a0 (mild\t\n \u00a0 to\t\n \u00a0\n\nmoderate)\t\n \u00a0and\t\n \u00a0GAS\t\n \u00a0(moderate\t\n \u00a0to\t\n \u00a0intense),\t\n \u00a0osteocalcin\t\n \u00a0(OC)\t\n \u00a0-\u00ad?\t\n \u00a0GSA\t\n \u00a0(intense)\t\n \u00a0and\t\n \u00a0GAS\t\n \u00a0\n\n(moderate).\t\n \u00a0Furthermore,\t\n \u00a0the\t\n \u00a0biology\t\n \u00a0of\t\n \u00a0bone\t\n \u00a0tissue\t\n \u00a0was\t\n \u00a0histologically\t\n \u00a0similar\t\n \u00a0in\t\n \u00a0both\t\n \u00a0\n\ngroups.\t\n \u00a0\n\n\t\n \u00a0 Conclusions:\t\n \u00a0Therefore,\t\n \u00a0it\t\n \u00a0was\t\n \u00a0concluded\t\n \u00a0that\t\n \u00a0hypertensive\t\n \u00a0subjects\t\n \u00a0treated\t\n \u00a0\n\nwith\t\n \u00a0renin-\u00ad?angiotensin\t\n \u00a0system\t\n \u00a0antagonists\t\n \u00a0have\t\n \u00a0great\t\n \u00a0bone\t\n \u00a0microstructural\t\n \u00a0similarity\t\n \u00a0\n\nand\t\n \u00a0also\t\n \u00a0cell\t\n \u00a0/\t\n \u00a0protein\t\n \u00a0to\t\n \u00a0normotensive\t\n \u00a0individuals.\t\n \u00a0\n\nKey-\u00ad?words:\t\n \u00a0hypertension,\t\n \u00a0dental\t\n \u00a0implants,\t\n \u00a0bone\t\n \u00a0and\t\n \u00a0bones.\t\n \u00a0\n\n\n\n23\t\n \u00a0\n\t\n \u00a0\n\n\t\n \u00a0\n\nIntrodu\u00e7\u00e3o\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\n\nA\t\n \u00a0hipertens\u00e3o\t\n \u00a0arterial\t\n \u00a0sist\u00eamica\t\n \u00a0(HAS)\t\n \u00a0foi\t\n \u00a0considerada\t\n \u00a0como\t\n \u00a0a\t\n \u00a0complica\u00e7\u00e3o\t\n \u00a0\n\ncardiovascular\t\n \u00a0mais\t\n \u00a0encontrada\t\n \u00a0em\t\n \u00a0todo\t\n \u00a0o\t\n \u00a0mundo\t\n \u00a0nas\t\n \u00a0\u00faltimas\t\n \u00a0duas\t\n \u00a0d\u00e9cadas\t\n \u00a0(Afghani\t\n \u00a0e\t\n \u00a0\n\nGoran,\t\n \u00a02007;\t\n \u00a0Otgontuya\t\n \u00a0et\t\n \u00a0al.,\t\n \u00a02013;\t\n \u00a0Tibazarwa\t\n \u00a0e\t\n \u00a0Damasceno,\t\n \u00a02014).\t\n \u00a0De\t\n \u00a0acordo\t\n \u00a0com\t\n \u00a0a\t\n \u00a0\n\npesquisa\t\n \u00a0Vigil\u00e2ncia\t\n \u00a0de\t\n \u00a0Fatores\t\n \u00a0de\t\n \u00a0Risco\t\n \u00a0e\t\n \u00a0Prote\u00e7\u00e3o\t\n \u00a0para\t\n \u00a0Doen\u00e7as\t\n \u00a0Cr\u00f4nicas\t\n \u00a0por\t\n \u00a0Inqu\u00e9rito\t\n \u00a0\n\nTelef\u00f4nico\t\n \u00a0 \u2013\t\n \u00a0 Vigitel\t\n \u00a0 de\t\n \u00a0 2014,\t\n \u00a0 24,8%\t\n \u00a0 da\t\n \u00a0 popula\u00e7\u00e3o\t\n \u00a0 brasileira\t\n \u00a0 apresenta\t\n \u00a0 hipertens\u00e3o\t\n \u00a0\n\narterial,\t\n \u00a0segundo\t\n \u00a0dados\t\n \u00a0da\t\n \u00a0American\t\n \u00a0Heart\t\n \u00a0Association\t\n \u00a02013,\t\n \u00a0uma\t\n \u00a0a\t\n \u00a0cada\t\n \u00a03\t\n \u00a0pessoas\t\n \u00a0na\t\n \u00a0\n\npopula\u00e7\u00e3o\t\n \u00a0adulta\t\n \u00a0dos\t\n \u00a0EUA\t\n \u00a0tem\t\n \u00a0hipertens\u00e3o.\t\n \u00a0Estima-\u00ad?se\t\n \u00a0que\t\n \u00a0cerca\t\n \u00a0de\t\n \u00a050%\t\n \u00a0dos\t\n \u00a0acidentes\t\n \u00a0\n\nvasculares\t\n \u00a0 encef\u00e1licos,\t\n \u00a0 42%\t\n \u00a0 das\t\n \u00a0 doen\u00e7as\t\n \u00a0 isqu\u00eamicas\t\n \u00a0 do\t\n \u00a0 cora\u00e7\u00e3o\t\n \u00a0 e\t\n \u00a0 22%\t\n \u00a0 de\t\n \u00a0 outras\t\n \u00a0\n\ncomplica\u00e7\u00f5es\t\n \u00a0cardiovasculares\t\n \u00a0em\t\n \u00a0homens\t\n \u00a0e\t\n \u00a0mulheres\t\n \u00a0com\t\n \u00a0idade\t\n \u00a0superior\t\n \u00a0a\t\n \u00a030\t\n \u00a0anos,\t\n \u00a0\n\ns\u00e3o\t\n \u00a0 decorrentes\t\n \u00a0 da\t\n \u00a0 HAS\t\n \u00a0 (Mohan\t\n \u00a0 et\t\n \u00a0 al.,\t\n \u00a0 2013;\t\n \u00a0 Gealh\t\n \u00a0 et\t\n \u00a0 al.,\t\n \u00a0 2014;\t\n \u00a0 Tibazarwa\t\n \u00a0 e\t\n \u00a0\n\nDamasceno,\t\n \u00a02014).\t\n \u00a0\n\nDentre\t\n \u00a0as\t\n \u00a0disfun\u00e7\u00f5es\t\n \u00a0metab\u00f3licas\t\n \u00a0observadas\t\n \u00a0na\t\n \u00a0hipertens\u00e3o\t\n \u00a0em\t\n \u00a0rela\u00e7\u00e3o\t\n \u00a0ao\t\n \u00a0\n\ntecido\t\n \u00a0 \u00f3sseo,\t\n \u00a0 \u00e9\t\n \u00a0 conhecido\t\n \u00a0 que\t\n \u00a0 indiv\u00edduos\t\n \u00a0 hipertensos\t\n \u00a0 apresentam\t\n \u00a0 metabolismo\t\n \u00a0\n\nanormal\t\n \u00a0de\t\n \u00a0c\u00e1lcio\t\n \u00a0resultando\t\n \u00a0em\t\n \u00a0concentra\u00e7\u00f5es\t\n \u00a0inferiores\t\n \u00a0desse\t\n \u00a0mineral,\t\n \u00a0de\t\n \u00a0vitamina\t\n \u00a0\n\nD,\t\n \u00a0magn\u00e9sio\t\n \u00a0e\t\n \u00a0altas\t\n \u00a0concentra\u00e7\u00f5es\t\n \u00a0de\t\n \u00a0horm\u00f4nio\t\n \u00a0da\t\n \u00a0paratireoide\t\n \u00a0(PTH)\t\n \u00a0(Mccarron\t\n \u00a0et\t\n \u00a0al.,\t\n \u00a0\n\n1981;\t\n \u00a0Wright\t\n \u00a0e\t\n \u00a0Rankin,\t\n \u00a01982;\t\n \u00a0Javed\t\n \u00a0et\t\n \u00a0al.,\t\n \u00a02012;\t\n \u00a0Pludowski\t\n \u00a0et\t\n \u00a0al.,\t\n \u00a02013),\t\n \u00a0prejudicando\t\n \u00a0a\t\n \u00a0\n\nqualidade\t\n \u00a0 e\t\n \u00a0 a\t\n \u00a0 densidade\t\n \u00a0 do\t\n \u00a0 tecido\t\n \u00a0 \u00f3sseo\t\n \u00a0 (Afghani\t\n \u00a0 e\t\n \u00a0 Goran,\t\n \u00a0 2007;\t\n \u00a0 Manrique\t\n \u00a0 et\t\n \u00a0 al.,\t\n \u00a0\n\n2012).\t\n \u00a0Portanto,\t\n \u00a0uma\t\n \u00a0quest\u00e3o\t\n \u00a0que\t\n \u00a0precisa\t\n \u00a0ser\t\n \u00a0abordada\t\n \u00a0de\t\n \u00a0forma\t\n \u00a0adequada,\t\n \u00a0refere-\u00ad?se\t\n \u00a0\n\n\u00e0\t\n \u00a0 qualidade\t\n \u00a0 do\t\n \u00a0 tecido\t\n \u00a0 \u00f3sseo\t\n \u00a0 em\t\n \u00a0 pacientes\t\n \u00a0 hipertensos,\t\n \u00a0 e\t\n \u00a0 ainda,\t\n \u00a0 a\t\n \u00a0 capacidade\t\n \u00a0 de\t\n \u00a0\n\nforma\u00e7\u00e3o\t\n \u00a0 \u00f3ssea\t\n \u00a0 em\t\n \u00a0 situa\u00e7\u00f5es\t\n \u00a0 como\t\n \u00a0 a\t\n \u00a0 osseointegra\u00e7\u00e3o\t\n \u00a0 ap\u00f3s\t\n \u00a0 a\t\n \u00a0 instala\u00e7\u00e3o\t\n \u00a0 desses\t\n \u00a0\n\nimplantes.\t\n \u00a0\n\n\n\n24\t\n \u00a0\n\t\n \u00a0\n\n\t\n \u00a0\n\nO\t\n \u00a0 sistema\t\n \u00a0 renina-\u00ad?angiotensina-\u00ad?aldoesterona\t\n \u00a0 (SRAA)\t\n \u00a0 consiste\t\n \u00a0 numa\t\n \u00a0 cascata\t\n \u00a0\n\nhormonal\t\n \u00a0 que\t\n \u00a0 atua\t\n \u00a0 como\t\n \u00a0 um\t\n \u00a0 dos\t\n \u00a0 principais\t\n \u00a0 controladores\t\n \u00a0 da\t\n \u00a0 press\u00e3o\t\n \u00a0 sangu\u00ednea\t\n \u00a0 e\t\n \u00a0\n\nvolume\t\n \u00a0de\t\n \u00a0fluidos\t\n \u00a0corporais\t\n \u00a0 (Haznedaroglu\t\n \u00a0e\t\n \u00a0Buyukasik,\t\n \u00a01997;\t\n \u00a0Namazi\t\n \u00a0et\t\n \u00a0al.,\t\n \u00a02011).\t\n \u00a0\n\nEstudos\t\n \u00a0recentes\t\n \u00a0mostraram\t\n \u00a0que\t\n \u00a0componentes\t\n \u00a0deste\t\n \u00a0sistema\t\n \u00a0como\t\n \u00a0a\t\n \u00a0renina,\t\n \u00a0a\t\n \u00a0enzima\t\n \u00a0\n\nconversora\t\n \u00a0de\t\n \u00a0angiotensina\t\n \u00a0e\t\n \u00a0receptores\t\n \u00a0da\t\n \u00a0angiotensina\t\n \u00a0II\t\n \u00a0(Ang\t\n \u00a0II),\t\n \u00a0s\u00e3o\t\n \u00a0expressos\t\n \u00a0no\t\n \u00a0\n\ntecido\t\n \u00a0 \u00f3sseo,\t\n \u00a0 tendo\t\n \u00a0 a\t\n \u00a0 Ang\t\n \u00a0 II\t\n \u00a0 a\t\n \u00a0 capacidade\t\n \u00a0 dede\t\n \u00a0 interferir\t\n \u00a0 atrav\u00e9s\t\n \u00a0 de\t\n \u00a0 receptores\t\n \u00a0\n\nlocalizados\t\n \u00a0nos\t\n \u00a0osteoblastos\t\n \u00a0e\t\n \u00a0osteoclastos\t\n \u00a0ou\t\n \u00a0pelo\t\n \u00a0fluxo\t\n \u00a0sangu\u00edneo\t\n \u00a0capilar\t\n \u00a0da\t\n \u00a0medula\t\n \u00a0\n\n\u00f3ssea.\t\n \u00a0 Existem\t\n \u00a0 dois\t\n \u00a0 principais\t\n \u00a0 subtipos\t\n \u00a0 de\t\n \u00a0 receptores\t\n \u00a0 da\t\n \u00a0 angiotensina,\t\n \u00a0 AT1\t\n \u00a0 e\t\n \u00a0 AT2\t\n \u00a0\n\n(Wright\t\n \u00a0e\t\n \u00a0Rankin,\t\n \u00a01982;\t\n \u00a0Whitebread\t\n \u00a0et\t\n \u00a0al.,\t\n \u00a01989;\t\n \u00a0Ludwig\t\n \u00a0et\t\n \u00a0al.,\t\n \u00a02013).\t\n \u00a0\n\nO\t\n \u00a0 losartan,\t\n \u00a0 droga\t\n \u00a0 da\t\n \u00a0 classe\t\n \u00a0 de\t\n \u00a0 antagonistas\t\n \u00a0 de\t\n \u00a0 receptor\t\n \u00a0 da\t\n \u00a0 Ang\t\n \u00a0 II,\t\n \u00a0 \u00e9\t\n \u00a0 um\t\n \u00a0\n\nf\u00e1rmaco\t\n \u00a0seletivo\t\n \u00a0e\t\n \u00a0age\t\n \u00a0especificamento\t\n \u00a0nos\t\n \u00a0receptores\t\n \u00a0de\t\n \u00a0AT1\t\n \u00a0da\t\n \u00a0Ang\t\n \u00a0II\t\n \u00a0no\t\n \u00a0m\u00fasculo\t\n \u00a0\n\nliso\t\n \u00a0 vascular\t\n \u00a0 e\t\n \u00a0 a\t\n \u00a0 gl\u00e2ndula\t\n \u00a0 supra-\u00ad?renal,\t\n \u00a0 tendo\t\n \u00a0 efeito\t\n \u00a0 vasoconstritor\t\n \u00a0 e\t\n \u00a0 de\t\n \u00a0 secre\u00e7\u00e3o\t\n \u00a0 de\t\n \u00a0\n\naldosterona.\t\n \u00a0Esta\t\n \u00a0\u00e9\t\n \u00a0uma\t\n \u00a0droga\t\n \u00a0de\t\n \u00a0interesse,\t\n \u00a0n\u00e3o\t\n \u00a0apenas\t\n \u00a0sua\t\n \u00a0efic\u00e1cia,\t\n \u00a0mas\t\n \u00a0tamb\u00e9m\t\n \u00a0por\t\n \u00a0\n\nter\t\n \u00a0a\t\n \u00a0capacidadede\t\n \u00a0proteger\t\n \u00a0\u00f3rg\u00e3os\t\n \u00a0alvo,\t\n \u00a0com\t\n \u00a0uma\t\n \u00a0baixa\t\n \u00a0incid\u00eancia\t\n \u00a0de\t\n \u00a0efeitos\t\n \u00a0adversos\t\n \u00a0\n\n(Broulik\t\n \u00a0et\t\n \u00a0al.,\t\n \u00a02001;\t\n \u00a0Al-\u00ad?Majed\t\n \u00a0et\t\n \u00a0al.,\t\n \u00a02015).\t\n \u00a0J\u00e1\t\n \u00a0o\t\n \u00a0captopril,\t\n \u00a0droga\t\n \u00a0pertencente\t\n \u00a0a\t\n \u00a0classe\t\n \u00a0\n\nde\t\n \u00a0inibidores\t\n \u00a0da\t\n \u00a0enzima\t\n \u00a0conversora\t\n \u00a0da\t\n \u00a0angiotensina\t\n \u00a0(ECA),\t\n \u00a0tem\t\n \u00a0efeito\t\n \u00a0de\t\n \u00a0inibir\t\n \u00a0toda\t\n \u00a0\n\ncascata\t\n \u00a0SRAA,\t\n \u00a0inclusive\t\n \u00a0a\t\n \u00a0forma\u00e7\u00e3o\t\n \u00a0de\t\n \u00a0Ang\t\n \u00a0II\t\n \u00a0e\t\n \u00a0seus\t\n \u00a0efeitos\t\n \u00a0(Diao\t\n \u00a0et\t\n \u00a0al.,\t\n \u00a02014;\t\n \u00a0Zhang\t\n \u00a0et\t\n \u00a0\n\nal.,\t\n \u00a02014).\t\n \u00a0\n\nO\t\n \u00a0SRAA\t\n \u00a0est\u00e1\t\n \u00a0presente\t\n \u00a0nos\t\n \u00a0tecidos\t\n \u00a0periodontais\t\n \u00a0de\t\n \u00a0humanos\t\n \u00a0e\t\n \u00a0em\t\n \u00a0ratos,\t\n \u00a0e\t\n \u00a0\n\nmostra\t\n \u00a0 uma\t\n \u00a0 a\u00e7\u00e3o\t\n \u00a0 funcional\t\n \u00a0 nos\t\n \u00a0 tecidos\t\n \u00a0 periodontais.\t\n \u00a0 Podendo\t\n \u00a0 assim,\t\n \u00a0 haver\t\n \u00a0 a\t\n \u00a0\n\npreven\u00e7\u00e3o\t\n \u00a0da\t\n \u00a0perda\t\n \u00a0\u00f3ssea\t\n \u00a0periodontal\t\n \u00a0em\t\n \u00a0ratos\t\n \u00a0com\t\n \u00a0periodontite\t\n \u00a0induzida\t\n \u00a0por\t\n \u00a0meio\t\n \u00a0\n\ndo\t\n \u00a0bloqueio\t\n \u00a0do\t\n \u00a0receptor\t\n \u00a0AT1\t\n \u00a0com\t\n \u00a0o\t\n \u00a0losartan\t\n \u00a0de\t\n \u00a0forma\t\n \u00a0significativa\t\n \u00a0(13).\t\n \u00a0\n\n\n\n25\t\n \u00a0\n\t\n \u00a0\n\n\t\n \u00a0\n\nInvestiga\u00e7\u00f5es\t\n \u00a0in\t\n \u00a0vitro\t\n \u00a0(Nishiya\t\n \u00a0e\t\n \u00a0Sugimoto,\t\n \u00a02001;\t\n \u00a0Nakai\t\n \u00a0et\t\n \u00a0al.,\t\n \u00a02013)\t\n \u00a0e\t\n \u00a0in\t\n \u00a0vivo\t\n \u00a0\n\n(Strawn\t\n \u00a0e\t\n \u00a0Ferrario,\t\n \u00a02008;\t\n \u00a0Donmez\t\n \u00a0et\t\n \u00a0al.,\t\n \u00a02012;\t\n \u00a0Pereira,\t\n \u00a02013;\t\n \u00a0Rajkumar\t\n \u00a0et\t\n \u00a0al.,\t\n \u00a02013)\t\n \u00a0\n\nmostraram\t\n \u00a0 uma\t\n \u00a0 participa\u00e7\u00e3o\t\n \u00a0 importante\t\n \u00a0 desta\t\n \u00a0 classe\t\n \u00a0 de\t\n \u00a0 medicamentos\t\n \u00a0 na\t\n \u00a0 melhora\t\n \u00a0\n\ndas\t\n \u00a0 respostas\t\n \u00a0 do\t\n \u00a0 metabolismo\t\n \u00a0 \u00f3sseo,\t\n \u00a0 aumentando\t\n \u00a0 a\t\n \u00a0 quantidade\t\n \u00a0 de\t\n \u00a0 osso\t\n \u00a0 formado,\t\n \u00a0\n\nbem\t\n \u00a0como\t\n \u00a0suas\t\n \u00a0caracter\u00edsticas\t\n \u00a0biomec\u00e2nicas\t\n \u00a0(Shimizu\t\n \u00a0et\t\n \u00a0al.,\t\n \u00a02008;\t\n \u00a0Nakai\t\n \u00a0et\t\n \u00a0al.,\t\n \u00a02013;\t\n \u00a0\n\nRajkumar\t\n \u00a0 et\t\n \u00a0 al.,\t\n \u00a0 2013;\t\n \u00a0 Zhang,\t\n \u00a0 Y.\t\n \u00a0 et\t\n \u00a0 al.,\t\n \u00a0 2013).\t\n \u00a0 Os\t\n \u00a0 bloqueadores\t\n \u00a0 dos\t\n \u00a0 receptores\t\n \u00a0 AT1\t\n \u00a0\n\ncomo\t\n \u00a0o\t\n \u00a0losartan,\t\n \u00a0parecem\t\n \u00a0agir\t\n \u00a0de\t\n \u00a0maneira\t\n \u00a0seletiva\t\n \u00a0nas\t\n \u00a0c\u00e9lulas\t\n \u00a0do\t\n \u00a0tecido\t\n \u00a0\u00f3sseo,\t\n \u00a0como\t\n \u00a0\n\nobservado\t\n \u00a0em\t\n \u00a0experimentos\t\n \u00a0de\t\n \u00a0cultura\t\n \u00a0de\t\n \u00a0c\u00e9lulas\t\n \u00a0(Nakai\t\n \u00a0et\t\n \u00a0al.,\t\n \u00a02013).\t\n \u00a0\n\nNo\t\n \u00a0entanto,\t\n \u00a0ainda\t\n \u00a0permanecem\t\n \u00a0d\u00favidas\t\n \u00a0e\t\n \u00a0algumas\t\n \u00a0controv\u00e9rsias\t\n \u00a0em\t\n \u00a0rela\u00e7\u00e3o\t\n \u00a0\n\n\u00e0\t\n \u00a0 a\u00e7\u00e3o\t\n \u00a0 destes\t\n \u00a0 medicamentos\t\n \u00a0 e\t\n \u00a0 faltam\t\n \u00a0 informa\u00e7\u00f5es\t\n \u00a0 consistentes\t\n \u00a0 quanto\t\n \u00a0 \u00e0s\t\n \u00a0 vias\t\n \u00a0 de\t\n \u00a0\n\nsinaliza\u00e7\u00e3o\t\n \u00a0 celulares\t\n \u00a0 envolvidas\t\n \u00a0 nas\t\n \u00a0 respostas\t\n \u00a0 j\u00e1\t\n \u00a0 observadas\t\n \u00a0 e\t\n \u00a0 tamb\u00e9m\t\n \u00a0 quanto\t\n \u00a0 a\t\n \u00a0\n\nmicroestrutura\t\n \u00a0\u00f3ssea\t\n \u00a0presente\t\n \u00a0nesses\t\n \u00a0casos\t\n \u00a0de\t\n \u00a0hipertens\u00e3o\t\n \u00a0compensada.\t\n \u00a0Tendo\t\n \u00a0em\t\n \u00a0\n\nvista\t\n \u00a0a\t\n \u00a0alta\t\n \u00a0frequ\u00eancia\t\n \u00a0de\t\n \u00a0extra\u00e7\u00f5es\t\n \u00a0dent\u00e1rias\t\n \u00a0e\t\n \u00a0o\t\n \u00a0aumento\t\n \u00a0da\t\n \u00a0procura\t\n \u00a0pela\t\n \u00a0instala\u00e7\u00e3o\t\n \u00a0\n\nde\t\n \u00a0implantes\t\n \u00a0osseointegr\u00e1veis,\t\n \u00a0faz-\u00ad?se\t\n \u00a0necess\u00e1ria\t\n \u00a0a\t\n \u00a0busca\t\n \u00a0por\t\n \u00a0respostas\t\n \u00a0do\t\n \u00a0tecido\t\n \u00a0\u00f3sseo\t\n \u00a0\n\ncomprometido\t\n \u00a0pela\t\n \u00a0hipertens\u00e3o,\t\n \u00a0mesmo\t\n \u00a0que\t\n \u00a0compensada\t\n \u00a0por\t\n \u00a0anti-\u00ad?hipertensivos.\t\n \u00a0\t\n \u00a0\n\nO\t\n \u00a0 presente\t\n \u00a0 estudo\t\n \u00a0 teve\t\n \u00a0 como\t\n \u00a0 objetivo\t\n \u00a0 caracterizar\t\n \u00a0 o\t\n \u00a0 tecido\t\n \u00a0 \u00f3sseo\t\n \u00a0\n\ncomprometido\t\n \u00a0 pela\t\n \u00a0 hipertens\u00e3o\t\n \u00a0 instalada,\t\n \u00a0 levando-\u00ad?se\t\n \u00a0 em\t\n \u00a0 conta\t\n \u00a0 a\t\n \u00a0 terapia\t\n \u00a0 anti-\u00ad?\n\nhipertensiva\t\n \u00a0 que\t\n \u00a0 tem\t\n \u00a0 sido\t\n \u00a0 bastante\t\n \u00a0 utilizada\t\n \u00a0 na\t\n \u00a0 atualidade,\t\n \u00a0 que\t\n \u00a0 s\u00e3o\t\n \u00a0 as\t\n \u00a0 medica\u00e7\u00f5es\t\n \u00a0\n\nantagonistas\t\n \u00a0 do\t\n \u00a0 SRAA.\t\n \u00a0 A\t\n \u00a0 caracteriza\u00e7\u00e3o\t\n \u00a0 ocorreu\t\n \u00a0 a\t\n \u00a0 partir\t\n \u00a0 de\t\n \u00a0 aspectos\t\n \u00a0 histol\u00f3gicos,\t\n \u00a0\n\nimunoistoqu\u00edmicos\t\n \u00a0e\t\n \u00a0microtomogr\u00e1ficos\t\n \u00a0tridimensionais\t\n \u00a0de\t\n \u00a0pacientes\t\n \u00a0com\t\n \u00a0hipertens\u00e3o\t\n \u00a0\n\nsubmetidos\t\n \u00a0 a\t\n \u00a0 instala\u00e7\u00e3o\t\n \u00a0 de\t\n \u00a0 implantes\t\n \u00a0 e\t\n \u00a0 tratados\t\n \u00a0 com\t\n \u00a0 medica\u00e7\u00f5es\t\n \u00a0 do\t\n \u00a0 SRAA\t\n \u00a0 ou\t\n \u00a0\n\npacientes\t\n \u00a0sem\t\n \u00a0altera\u00e7\u00e3o\t\n \u00a0sist\u00eamica\t\n \u00a0(normotensos).\t\n \u00a0\n\n\t\n \u00a0\n\n\n\n48\t\n \u00a0\n\t\n \u00a0\n\n\t\n \u00a0\n\nRefer\u00eancias\t\n \u00a0\n\n \nAFGHANI,\t\n \u00a0 A.;\t\n \u00a0 GORAN,\t\n \u00a0 M.\t\n \u00a0 I.\t\n \u00a0 Lower\t\n \u00a0 bone\t\n \u00a0 mineral\t\n \u00a0 content\t\n \u00a0 in\t\n \u00a0 hypertensive\t\n \u00a0 compared\t\n \u00a0 with\t\n \u00a0\nnormotensive\t\n \u00a0overweight\t\n \u00a0Latino\t\n \u00a0children\t\n \u00a0and\t\n \u00a0adolescents.\t\n \u00a0Am\t\n \u00a0J\t\n \u00a0Hypertens,\t\n \u00a0v.\t\n \u00a020,\t\n \u00a0n.\t\n \u00a02,\t\n \u00a0p.\t\n \u00a0190-\u00ad?\n6,\t\n \u00a0Feb\t\n \u00a02007.\t\n \u00a0ISSN\t\n \u00a00895-\u00ad?7061\t\n \u00a0(Print)\t\n \u00a0\n\n0895-\u00ad?7061.\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\nAL-\u00ad?MAJED,\t\n \u00a0 A.\t\n \u00a0 R.\t\n \u00a0 \t\n \u00a0 et\t\n \u00a0 al.\t\n \u00a0 Losartan:\t\n \u00a0 Comprehensive\t\n \u00a0 Profile.\t\n \u00a0 Profiles\t\n \u00a0 Drug\t\n \u00a0 Subst\t\n \u00a0 Excip\t\n \u00a0 Relat\t\n \u00a0\nMethodol,\t\n \u00a0v.\t\n \u00a040,\t\n \u00a0p.\t\n \u00a0159-\u00ad?94,\t\n \u00a0\t\n \u00a02015.\t\n \u00a0ISSN\t\n \u00a01871-\u00ad?5125\t\n \u00a0(Print)\t\n \u00a0\n\n1871-\u00ad?5125.\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\nBOUXSEIN,\t\n \u00a0 M.\t\n \u00a0 L.\t\n \u00a0 \t\n \u00a0 et\t\n \u00a0 al.\t\n \u00a0 Guidelines\t\n \u00a0 for\t\n \u00a0 assessment\t\n \u00a0 of\t\n \u00a0 bone\t\n \u00a0 microstructure\t\n \u00a0 in\t\n \u00a0 rodents\t\n \u00a0 using\t\n \u00a0\nmicro-\u00ad?computed\t\n \u00a0tomography.\t\n \u00a0J\t\n \u00a0Bone\t\n \u00a0Miner\t\n \u00a0Res,\t\n \u00a0v.\t\n \u00a025,\t\n \u00a0n.\t\n \u00a07,\t\n \u00a0p.\t\n \u00a01468-\u00ad?86,\t\n \u00a0Jul\t\n \u00a02010.\t\n \u00a0ISSN\t\n \u00a01523-\u00ad?\n4681\t\n \u00a0 (Electronic)\t\n \u00a0 0884-\u00ad?0431\t\n \u00a0 (Linking).\t\n \u00a0 Dispon\u00edvel\t\n \u00a0 em:\t\n \u00a0&lt;\t\n \u00a0\nhttp://www.ncbi.nlm.nih.gov/pubmed/20533309\t\n \u00a0>.\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\nBROULIK,\t\n \u00a0P.\t\n \u00a0D.\t\n \u00a0\t\n \u00a0et\t\n \u00a0al.\t\n \u00a0Impact\t\n \u00a0of\t\n \u00a0antihypertensive\t\n \u00a0therapy\t\n \u00a0on\t\n \u00a0the\t\n \u00a0skeleton:\t\n \u00a0effects\t\n \u00a0of\t\n \u00a0enalapril\t\n \u00a0\nand\t\n \u00a0AT1\t\n \u00a0receptor\t\n \u00a0antagonist\t\n \u00a0losartan\t\n \u00a0in\t\n \u00a0female\t\n \u00a0rats.\t\n \u00a0Physiol\t\n \u00a0Res,\t\n \u00a0v.\t\n \u00a050,\t\n \u00a0n.\t\n \u00a04,\t\n \u00a0p.\t\n \u00a0353-\u00ad?8,\t\n \u00a0\t\n \u00a02001.\t\n \u00a0\nISSN\t\n \u00a00862-\u00ad?8408\t\n \u00a0(Print)\t\n \u00a0\n\n0862-\u00ad?8408.\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\nCHEN,\t\n \u00a0 S.\t\n \u00a0 \t\n \u00a0 et\t\n \u00a0 al.\t\n \u00a0 Losartan\t\n \u00a0 increases\t\n \u00a0 bone\t\n \u00a0 mass\t\n \u00a0 and\t\n \u00a0 accelerates\t\n \u00a0 chondrocyte\t\n \u00a0 hypertrophy\t\n \u00a0 in\t\n \u00a0\ndeveloping\t\n \u00a0skeleton.\t\n \u00a0Mol\t\n \u00a0Genet\t\n \u00a0Metab,\t\n \u00a0v.\t\n \u00a0115,\t\n \u00a0n.\t\n \u00a01,\t\n \u00a0p.\t\n \u00a053-\u00ad?60,\t\n \u00a0May\t\n \u00a02015.\t\n \u00a0ISSN\t\n \u00a01096-\u00ad?7192.\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\nDIAO,\t\n \u00a0T.\t\n \u00a0Y.\t\n \u00a0\t\n \u00a0et\t\n \u00a0al.\t\n \u00a0Effects\t\n \u00a0of\t\n \u00a0angiotensin-\u00ad?converting\t\n \u00a0enzyme\t\n \u00a0inhibitor,\t\n \u00a0captopril,\t\n \u00a0on\t\n \u00a0bone\t\n \u00a0of\t\n \u00a0mice\t\n \u00a0\nwith\t\n \u00a0streptozotocin-\u00ad?induced\t\n \u00a0type\t\n \u00a01\t\n \u00a0diabetes.\t\n \u00a0J\t\n \u00a0Bone\t\n \u00a0Miner\t\n \u00a0Metab,\t\n \u00a0v.\t\n \u00a032,\t\n \u00a0n.\t\n \u00a03,\t\n \u00a0p.\t\n \u00a0261-\u00ad?70,\t\n \u00a0May\t\n \u00a0\n2014.\t\n \u00a0ISSN\t\n \u00a00914-\u00ad?8779.\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\nDONMEZ,\t\n \u00a0 B.\t\n \u00a0 O.\t\n \u00a0 \t\n \u00a0 et\t\n \u00a0 al.\t\n \u00a0 Effect\t\n \u00a0 of\t\n \u00a0 angiotensin\t\n \u00a0 II\t\n \u00a0 type\t\n \u00a0 1\t\n \u00a0 receptor\t\n \u00a0 blocker\t\n \u00a0 on\t\n \u00a0 osteoporotic\t\n \u00a0 rat\t\n \u00a0\nfemurs.\t\n \u00a0Pharmacol\t\n \u00a0Rep,\t\n \u00a0v.\t\n \u00a064,\t\n \u00a0n.\t\n \u00a04,\t\n \u00a0p.\t\n \u00a0878-\u00ad?88,\t\n \u00a0\t\n \u00a02012.\t\n \u00a0ISSN\t\n \u00a01734-\u00ad?1140\t\n \u00a0(Print)\t\n \u00a0\n\n1734-\u00ad?1140.\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\nGEALH,\t\n \u00a0W.\t\n \u00a0C.\t\n \u00a0\t\n \u00a0et\t\n \u00a0al.\t\n \u00a0Healing\t\n \u00a0process\t\n \u00a0of\t\n \u00a0autogenous\t\n \u00a0bone\t\n \u00a0graft\t\n \u00a0in\t\n \u00a0spontaneously\t\n \u00a0hypertensive\t\n \u00a0\nrats\t\n \u00a0 treated\t\n \u00a0 with\t\n \u00a0 losartan:\t\n \u00a0 an\t\n \u00a0 immunohistochemical\t\n \u00a0 and\t\n \u00a0 histomorphometric\t\n \u00a0 study.\t\n \u00a0 J\t\n \u00a0 Oral\t\n \u00a0\nMaxillofac\t\n \u00a0Surg,\t\n \u00a0v.\t\n \u00a072,\t\n \u00a0n.\t\n \u00a012,\t\n \u00a0p.\t\n \u00a02569-\u00ad?81,\t\n \u00a0Dec\t\n \u00a02014.\t\n \u00a0ISSN\t\n \u00a00278-\u00ad?2391.\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\nHAZNEDAROGLU,\t\n \u00a0 I.\t\n \u00a0 C.;\t\n \u00a0 BUYUKASIK,\t\n \u00a0 Y.\t\n \u00a0 Current\t\n \u00a0 evidence\t\n \u00a0 for\t\n \u00a0 the\t\n \u00a0 existence\t\n \u00a0 of\t\n \u00a0 a\t\n \u00a0 local\t\n \u00a0 renin-\u00ad?\nangiotensin\t\n \u00a0system\t\n \u00a0affecting\t\n \u00a0physiological\t\n \u00a0and\t\n \u00a0pathological\t\n \u00a0haemopoiesis\t\n \u00a0in\t\n \u00a0the\t\n \u00a0bone\t\n \u00a0marrow.\t\n \u00a0\nBr\t\n \u00a0J\t\n \u00a0Haematol,\t\n \u00a0v.\t\n \u00a099,\t\n \u00a0n.\t\n \u00a02,\t\n \u00a0p.\t\n \u00a0471,\t\n \u00a0Nov\t\n \u00a01997.\t\n \u00a0ISSN\t\n \u00a00007-\u00ad?1048\t\n \u00a0(Print)\t\n \u00a0\n\n0007-\u00ad?1048.\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\n\n49\t\n \u00a0\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\nJAVED,\t\n \u00a0F.\t\n \u00a0 \t\n \u00a0et\t\n \u00a0al.\t\n \u00a0Association\t\n \u00a0of\t\n \u00a0hypertension\t\n \u00a0and\t\n \u00a0bone\t\n \u00a0mineral\t\n \u00a0density\t\n \u00a0 in\t\n \u00a0an\t\n \u00a0elderly\t\n \u00a0African\t\n \u00a0\nAmerican\t\n \u00a0female\t\n \u00a0population.\t\n \u00a0J\t\n \u00a0Natl\t\n \u00a0Med\t\n \u00a0Assoc,\t\n \u00a0v.\t\n \u00a0104,\t\n \u00a0n.\t\n \u00a03-\u00ad?4,\t\n \u00a0p.\t\n \u00a0172-\u00ad?8,\t\n \u00a0Mar-\u00ad?Apr\t\n \u00a02012.\t\n \u00a0ISSN\t\n \u00a0\n0027-\u00ad?9684\t\n \u00a0(Print)\t\n \u00a0\n\n0027-\u00ad?9684.\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\nLUDWIG,\t\n \u00a0M.\t\n \u00a0\t\n \u00a0et\t\n \u00a0al.\t\n \u00a0Characterization\t\n \u00a0of\t\n \u00a0ion\t\n \u00a0currents\t\n \u00a0of\t\n \u00a0murine\t\n \u00a0CD117(pos)\t\n \u00a0stem\t\n \u00a0cells\t\n \u00a0in\t\n \u00a0vitro\t\n \u00a0\nand\t\n \u00a0their\t\n \u00a0modulation\t\n \u00a0under\t\n \u00a0AT2\t\n \u00a0R\t\n \u00a0stimulation.\t\n \u00a0Acta\t\n \u00a0Physiol\t\n \u00a0(Oxf),\t\n \u00a0v.\t\n \u00a0208,\t\n \u00a0n.\t\n \u00a03,\t\n \u00a0p.\t\n \u00a0274-\u00ad?87,\t\n \u00a0Jul\t\n \u00a0\n2013.\t\n \u00a0ISSN\t\n \u00a01748-\u00ad?1708.\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\nMANRIQUE,\t\n \u00a0N.\t\n \u00a0\t\n \u00a0et\t\n \u00a0al.\t\n \u00a0Alveolar\t\n \u00a0bone\t\n \u00a0healing\t\n \u00a0process\t\n \u00a0in\t\n \u00a0spontaneously\t\n \u00a0hypertensive\t\n \u00a0rats\t\n \u00a0(SHR).\t\n \u00a0\nA\t\n \u00a0radiographic\t\n \u00a0densitometry\t\n \u00a0study.\t\n \u00a0J\t\n \u00a0Appl\t\n \u00a0Oral\t\n \u00a0Sci,\t\n \u00a0v.\t\n \u00a020,\t\n \u00a0n.\t\n \u00a02,\t\n \u00a0p.\t\n \u00a0222-\u00ad?7,\t\n \u00a0Mar-\u00ad?Apr\t\n \u00a02012.\t\n \u00a0ISSN\t\n \u00a0\n1678-\u00ad?7757.\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\n______.\t\n \u00a0Hypertension\t\n \u00a0modifies\t\n \u00a0OPG,\t\n \u00a0RANK,\t\n \u00a0and\t\n \u00a0RANKL\t\n \u00a0expression\t\n \u00a0during\t\n \u00a0the\t\n \u00a0dental\t\n \u00a0socket\t\n \u00a0\nbone\t\n \u00a0 healing\t\n \u00a0 process\t\n \u00a0 in\t\n \u00a0 spontaneously\t\n \u00a0 hypertensive\t\n \u00a0 rats.\t\n \u00a0 Clin\t\n \u00a0 Oral\t\n \u00a0 Investig,\t\n \u00a0 v.\t\n \u00a0 19,\t\n \u00a0 n.\t\n \u00a0 6,\t\n \u00a0 p.\t\n \u00a0\n1319-\u00ad?27,\t\n \u00a0Jul\t\n \u00a02015.\t\n \u00a0ISSN\t\n \u00a01432-\u00ad?6981.\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\nMCCARRON,\t\n \u00a0 D.\t\n \u00a0 A.\t\n \u00a0 \t\n \u00a0 et\t\n \u00a0 al.\t\n \u00a0 Disturbances\t\n \u00a0 of\t\n \u00a0 calcium\t\n \u00a0 metabolism\t\n \u00a0 in\t\n \u00a0 the\t\n \u00a0 spontaneously\t\n \u00a0\nhypertensive\t\n \u00a0rat.\t\n \u00a0Hypertension,\t\n \u00a0v.\t\n \u00a03,\t\n \u00a0n.\t\n \u00a03\t\n \u00a0Pt\t\n \u00a02,\t\n \u00a0p.\t\n \u00a0I162-\u00ad?7,\t\n \u00a0May-\u00ad?Jun\t\n \u00a01981.\t\n \u00a0ISSN\t\n \u00a00194-\u00ad?911X\t\n \u00a0(Print)\t\n \u00a0\n\n0194-\u00ad?911x.\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\nMOHAN,\t\n \u00a0V.;\t\n \u00a0SEEDAT,\t\n \u00a0Y.\t\n \u00a0K.;\t\n \u00a0PRADEEPA,\t\n \u00a0R.\t\n \u00a0The\t\n \u00a0rising\t\n \u00a0burden\t\n \u00a0of\t\n \u00a0diabetes\t\n \u00a0and\t\n \u00a0hypertension\t\n \u00a0in\t\n \u00a0\nsoutheast\t\n \u00a0asian\t\n \u00a0and\t\n \u00a0african\t\n \u00a0regions:\t\n \u00a0need\t\n \u00a0for\t\n \u00a0effective\t\n \u00a0strategies\t\n \u00a0for\t\n \u00a0prevention\t\n \u00a0and\t\n \u00a0control\t\n \u00a0in\t\n \u00a0\nprimary\t\n \u00a0 health\t\n \u00a0 care\t\n \u00a0 settings.\t\n \u00a0 Int\t\n \u00a0 J\t\n \u00a0 Hypertens,\t\n \u00a0 v.\t\n \u00a0 2013,\t\n \u00a0 p.\t\n \u00a0 409083,\t\n \u00a0 \t\n \u00a0 2013.\t\n \u00a0 ISSN\t\n \u00a0 2090-\u00ad?0384\t\n \u00a0\n(Print).\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\nMOURA,\t\n \u00a0A.\t\n \u00a0P.\t\n \u00a0\t\n \u00a0et\t\n \u00a0al.\t\n \u00a0Effects\t\n \u00a0of\t\n \u00a0angiotensin\t\n \u00a0II\t\n \u00a0type\t\n \u00a0I\t\n \u00a0receptor\t\n \u00a0blocker\t\n \u00a0losartan\t\n \u00a0on\t\n \u00a0orthodontic\t\n \u00a0\ntooth\t\n \u00a0movement.\t\n \u00a0Am\t\n \u00a0J\t\n \u00a0Orthod\t\n \u00a0Dentofacial\t\n \u00a0Orthop,\t\n \u00a0v.\t\n \u00a0149,\t\n \u00a0n.\t\n \u00a03,\t\n \u00a0p.\t\n \u00a0358-\u00ad?65,\t\n \u00a0Mar\t\n \u00a02016.\t\n \u00a0ISSN\t\n \u00a0\n0889-\u00ad?5406.\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\nNAKAI,\t\n \u00a0K.\t\n \u00a0 \t\n \u00a0et\t\n \u00a0al.\t\n \u00a0Angiotensin\t\n \u00a0II\t\n \u00a0 induces\t\n \u00a0the\t\n \u00a0production\t\n \u00a0of\t\n \u00a0MMP-\u00ad?3\t\n \u00a0and\t\n \u00a0MMP-\u00ad?13\t\n \u00a0through\t\n \u00a0the\t\n \u00a0\nMAPK\t\n \u00a0signaling\t\n \u00a0pathways\t\n \u00a0via\t\n \u00a0the\t\n \u00a0AT(1)\t\n \u00a0receptor\t\n \u00a0in\t\n \u00a0osteoblasts.\t\n \u00a0Biochimie,\t\n \u00a0v.\t\n \u00a095,\t\n \u00a0n.\t\n \u00a04,\t\n \u00a0p.\t\n \u00a0922-\u00ad?\n33,\t\n \u00a0Apr\t\n \u00a02013.\t\n \u00a0ISSN\t\n \u00a00300-\u00ad?9084.\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\nNAMAZI,\t\n \u00a0 S.;\t\n \u00a0 ARDESHIR-\u00ad?ROUHANI-\u00ad?FARD,\t\n \u00a0 S.;\t\n \u00a0 ABEDTASH,\t\n \u00a0 H.\t\n \u00a0 The\t\n \u00a0 effect\t\n \u00a0 of\t\n \u00a0 renin\t\n \u00a0 angiotensin\t\n \u00a0\nsystem\t\n \u00a0on\t\n \u00a0tamoxifen\t\n \u00a0resistance.\t\n \u00a0Med\t\n \u00a0Hypotheses,\t\n \u00a0v.\t\n \u00a077,\t\n \u00a0n.\t\n \u00a01,\t\n \u00a0p.\t\n \u00a0152-\u00ad?5,\t\n \u00a0Jul\t\n \u00a02011.\t\n \u00a0ISSN\t\n \u00a00306-\u00ad?\n9877.\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\nNISHIYA,\t\n \u00a0 Y.;\t\n \u00a0 SUGIMOTO,\t\n \u00a0 S.\t\n \u00a0 Effects\t\n \u00a0 of\t\n \u00a0 various\t\n \u00a0 antihypertensive\t\n \u00a0 drugs\t\n \u00a0 on\t\n \u00a0 the\t\n \u00a0 function\t\n \u00a0 of\t\n \u00a0\nosteoblast.\t\n \u00a0Biol\t\n \u00a0Pharm\t\n \u00a0Bull,\t\n \u00a0v.\t\n \u00a024,\t\n \u00a0n.\t\n \u00a06,\t\n \u00a0p.\t\n \u00a0628-\u00ad?33,\t\n \u00a0Jun\t\n \u00a02001.\t\n \u00a0ISSN\t\n \u00a00918-\u00ad?6158\t\n \u00a0(Print)\t\n \u00a0\n\n0918-\u00ad?6158.\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\n\n50\t\n \u00a0\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\nOTGONTUYA,\t\n \u00a0D.\t\n \u00a0\t\n \u00a0et\t\n \u00a0al.\t\n \u00a0Assessment\t\n \u00a0of\t\n \u00a0total\t\n \u00a0cardiovascular\t\n \u00a0risk\t\n \u00a0using\t\n \u00a0WHO/ISH\t\n \u00a0risk\t\n \u00a0prediction\t\n \u00a0\ncharts\t\n \u00a0 in\t\n \u00a0three\t\n \u00a0 low\t\n \u00a0and\t\n \u00a0middle\t\n \u00a0 income\t\n \u00a0countries\t\n \u00a0 in\t\n \u00a0Asia.\t\n \u00a0 BMC\t\n \u00a0Public\t\n \u00a0Health,\t\n \u00a0v.\t\n \u00a013,\t\n \u00a0p.\t\n \u00a0539,\t\n \u00a0\t\n \u00a0\n2013.\t\n \u00a0ISSN\t\n \u00a01471-\u00ad?2458.\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\nPEDROSA,\t\n \u00a0W.\t\n \u00a0F.,\t\n \u00a0JR.\t\n \u00a0\t\n \u00a0et\t\n \u00a0al.\t\n \u00a0Immunohistochemical,\t\n \u00a0tomographic\t\n \u00a0and\t\n \u00a0histological\t\n \u00a0study\t\n \u00a0on\t\n \u00a0onlay\t\n \u00a0\nbone\t\n \u00a0graft\t\n \u00a0remodeling.\t\n \u00a0Part\t\n \u00a0II:\t\n \u00a0calvarial\t\n \u00a0bone.\t\n \u00a0Clin\t\n \u00a0Oral\t\n \u00a0Implants\t\n \u00a0Res,\t\n \u00a0v.\t\n \u00a020,\t\n \u00a0n.\t\n \u00a011,\t\n \u00a0p.\t\n \u00a01254-\u00ad?64,\t\n \u00a0\nNov\t\n \u00a0 2009.\t\n \u00a0 ISSN\t\n \u00a0 1600-\u00ad?0501\t\n \u00a0 (Electronic)\t\n \u00a0 0905-\u00ad?7161\t\n \u00a0 (Linking).\t\n \u00a0 Dispon\u00edvel\t\n \u00a0 em:\t\n \u00a0&lt;\t\n \u00a0\nhttp://www.ncbi.nlm.nih.gov/pubmed/19531103\t\n \u00a0>.\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\nPEREIRA,\t\n \u00a0C.\t\n \u00a0An\u00e1lise\t\n \u00a0do\t\n \u00a0processo\t\n \u00a0de\t\n \u00a0reparo\t\n \u00a0alveolar\t\n \u00a0em\t\n \u00a0ratos\t\n \u00a0espontaneamente\t\n \u00a0hipertensos\t\n \u00a0\n(SHR)\t\n \u00a0n\u00e3o\t\n \u00a0tratados\t\n \u00a0e\t\n \u00a0tratados\t\n \u00a0com\t\n \u00a0losartan.\t\n \u00a0Estudo\t\n \u00a0imunoistoqu\u00edmico\t\n \u00a0e\t\n \u00a0histomorfom\u00e9trico.\t\n \u00a0\nhttp://unesp.br/portal/cgb/bibliotecas-\u00ad?digitais/cthedra-\u00ad?biblioteca-\u00ad?digital-\u00ad?teses/:\t\n \u00a0 Aracatuba\t\n \u00a0\nDental\t\n \u00a0School\t\n \u00a0(Univ.\t\n \u00a0Estadual\t\n \u00a0Paulista\t\n \u00a0-\u00ad?\t\n \u00a0UNESP)\t\n \u00a02013.\t\n \u00a0\n\n\t\n \u00a0\nPLUDOWSKI,\t\n \u00a0 P.\t\n \u00a0 \t\n \u00a0 et\t\n \u00a0 al.\t\n \u00a0 Vitamin\t\n \u00a0 D\t\n \u00a0 status,\t\n \u00a0 body\t\n \u00a0 composition\t\n \u00a0 and\t\n \u00a0 hypertensive\t\n \u00a0 target\t\n \u00a0 organ\t\n \u00a0\ndamage\t\n \u00a0in\t\n \u00a0primary\t\n \u00a0hypertension.\t\n \u00a0J\t\n \u00a0Steroid\t\n \u00a0Biochem\t\n \u00a0Mol\t\n \u00a0Biol,\t\n \u00a0Nov\t\n \u00a01\t\n \u00a02013.\t\n \u00a0ISSN\t\n \u00a00960-\u00ad?0760.\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\nRAJKUMAR,\t\n \u00a0D.\t\n \u00a0S.\t\n \u00a0\t\n \u00a0et\t\n \u00a0al.\t\n \u00a0Comparative\t\n \u00a0evaluation\t\n \u00a0of\t\n \u00a0enalapril\t\n \u00a0and\t\n \u00a0losartan\t\n \u00a0in\t\n \u00a0pharmacological\t\n \u00a0\ncorrection\t\n \u00a0 of\t\n \u00a0 experimental\t\n \u00a0 osteoporosis\t\n \u00a0 and\t\n \u00a0 fractures\t\n \u00a0 of\t\n \u00a0 its\t\n \u00a0 background.\t\n \u00a0 J\t\n \u00a0 Osteoporos,\t\n \u00a0 v.\t\n \u00a0\n2013,\t\n \u00a0p.\t\n \u00a0325693,\t\n \u00a0\t\n \u00a02013.\t\n \u00a0ISSN\t\n \u00a02090-\u00ad?8059\t\n \u00a0(Print)\t\n \u00a0\n\n2042-\u00ad?0064.\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\nSHIMIZU,\t\n \u00a0H.\t\n \u00a0\t\n \u00a0et\t\n \u00a0al.\t\n \u00a0Angiotensin\t\n \u00a0II\t\n \u00a0accelerates\t\n \u00a0osteoporosis\t\n \u00a0by\t\n \u00a0activating\t\n \u00a0osteoclasts.\t\n \u00a0Faseb\t\n \u00a0j,\t\n \u00a0v.\t\n \u00a0\n22,\t\n \u00a0n.\t\n \u00a07,\t\n \u00a0p.\t\n \u00a02465-\u00ad?75,\t\n \u00a0Jul\t\n \u00a02008.\t\n \u00a0ISSN\t\n \u00a00892-\u00ad?6638.\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\nSTRAWN,\t\n \u00a0 W.\t\n \u00a0 B.;\t\n \u00a0 FERRARIO,\t\n \u00a0 C.\t\n \u00a0 M.\t\n \u00a0 Angiotensin\t\n \u00a0 II\t\n \u00a0 AT1\t\n \u00a0 receptor\t\n \u00a0 blockade\t\n \u00a0 normalizes\t\n \u00a0 CD11b+\t\n \u00a0\nmonocyte\t\n \u00a0production\t\n \u00a0in\t\n \u00a0bone\t\n \u00a0marrow\t\n \u00a0of\t\n \u00a0hypercholesterolemic\t\n \u00a0monkeys.\t\n \u00a0Atherosclerosis,\t\n \u00a0v.\t\n \u00a0\n196,\t\n \u00a0n.\t\n \u00a02,\t\n \u00a0p.\t\n \u00a0624-\u00ad?32,\t\n \u00a0Feb\t\n \u00a02008.\t\n \u00a0ISSN\t\n \u00a00021-\u00ad?9150.\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\nTIBAZARWA,\t\n \u00a0K.\t\n \u00a0B.;\t\n \u00a0DAMASCENO,\t\n \u00a0A.\t\n \u00a0A.\t\n \u00a0Hypertension\t\n \u00a0in\t\n \u00a0developing\t\n \u00a0countries.\t\n \u00a0Can\t\n \u00a0J\t\n \u00a0Cardiol,\t\n \u00a0v.\t\n \u00a0\n30,\t\n \u00a0n.\t\n \u00a05,\t\n \u00a0p.\t\n \u00a0527-\u00ad?33,\t\n \u00a0May\t\n \u00a02014.\t\n \u00a0ISSN\t\n \u00a00828-\u00ad?282x.\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\nWHITEBREAD,\t\n \u00a0S.\t\n \u00a0\t\n \u00a0et\t\n \u00a0al.\t\n \u00a0Preliminary\t\n \u00a0biochemical\t\n \u00a0characterization\t\n \u00a0of\t\n \u00a0two\t\n \u00a0angiotensin\t\n \u00a0II\t\n \u00a0receptor\t\n \u00a0\nsubtypes.\t\n \u00a0Biochem\t\n \u00a0Biophys\t\n \u00a0Res\t\n \u00a0Commun,\t\n \u00a0v.\t\n \u00a0163,\t\n \u00a0n.\t\n \u00a01,\t\n \u00a0p.\t\n \u00a0284-\u00ad?91,\t\n \u00a0Aug\t\n \u00a030\t\n \u00a01989.\t\n \u00a0ISSN\t\n \u00a00006-\u00ad?291X\t\n \u00a0\n(Print)\t\n \u00a0\n\n0006-\u00ad?291x.\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\nWRIGHT,\t\n \u00a0 G.\t\n \u00a0 L.;\t\n \u00a0 RANKIN,\t\n \u00a0 G.\t\n \u00a0 O.\t\n \u00a0 Concentrations\t\n \u00a0 of\t\n \u00a0 ionic\t\n \u00a0 and\t\n \u00a0 total\t\n \u00a0 calcium\t\n \u00a0 in\t\n \u00a0 plasma\t\n \u00a0 of\t\n \u00a0 four\t\n \u00a0\nmodels\t\n \u00a0 of\t\n \u00a0 hypertension.\t\n \u00a0 Am\t\n \u00a0 J\t\n \u00a0 Physiol,\t\n \u00a0 v.\t\n \u00a0 243,\t\n \u00a0 n.\t\n \u00a0 3,\t\n \u00a0 p.\t\n \u00a0 H365-\u00ad?70,\t\n \u00a0 Sep\t\n \u00a0 1982.\t\n \u00a0 ISSN\t\n \u00a0 0002-\u00ad?9513\t\n \u00a0\n(Print)\t\n \u00a0\n\n0002-\u00ad?9513.\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\n\n51\t\n \u00a0\n\t\n \u00a0\n\n\t\n \u00a0\n\n\t\n \u00a0\nYOU,\t\n \u00a0D.\t\n \u00a0\t\n \u00a0et\t\n \u00a0al.\t\n \u00a0Hypertension\t\n \u00a0impairs\t\n \u00a0postnatal\t\n \u00a0vasculogenesis:\t\n \u00a0role\t\n \u00a0of\t\n \u00a0antihypertensive\t\n \u00a0agents.\t\n \u00a0\nHypertension,\t\n \u00a0v.\t\n \u00a051,\t\n \u00a0n.\t\n \u00a06,\t\n \u00a0p.\t\n \u00a01537-\u00ad?44,\t\n \u00a0Jun\t\n \u00a02008.\t\n \u00a0ISSN\t\n \u00a00194-\u00ad?911x.\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\nZHANG,\t\n \u00a0Y.\t\n \u00a0\t\n \u00a0et\t\n \u00a0al.\t\n \u00a0Effects\t\n \u00a0of\t\n \u00a0angiotensin\t\n \u00a0II\t\n \u00a0type\t\n \u00a01\t\n \u00a0receptor\t\n \u00a0blocker\t\n \u00a0on\t\n \u00a0bones\t\n \u00a0in\t\n \u00a0mice\t\n \u00a0with\t\n \u00a0type\t\n \u00a01\t\n \u00a0\ndiabetes\t\n \u00a0induced\t\n \u00a0by\t\n \u00a0streptozotocin.\t\n \u00a0J\t\n \u00a0Renin\t\n \u00a0Angiotensin\t\n \u00a0Aldosterone\t\n \u00a0Syst,\t\n \u00a0Jan\t\n \u00a02\t\n \u00a02013.\t\n \u00a0ISSN\t\n \u00a0\n1470-\u00ad?3203.\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\n______.\t\n \u00a0Effects\t\n \u00a0of\t\n \u00a0angiotensin\t\n \u00a0II\t\n \u00a0type\t\n \u00a01\t\n \u00a0receptor\t\n \u00a0blocker\t\n \u00a0on\t\n \u00a0bones\t\n \u00a0in\t\n \u00a0mice\t\n \u00a0with\t\n \u00a0type\t\n \u00a01\t\n \u00a0diabetes\t\n \u00a0\ninduced\t\n \u00a0by\t\n \u00a0streptozotocin.\t\n \u00a0J\t\n \u00a0Renin\t\n \u00a0Angiotensin\t\n \u00a0Aldosterone\t\n \u00a0Syst,\t\n \u00a0v.\t\n \u00a015,\t\n \u00a0n.\t\n \u00a03,\t\n \u00a0p.\t\n \u00a0218-\u00ad?27,\t\n \u00a0Sep\t\n \u00a0\n2014.\t\n \u00a0ISSN\t\n \u00a01470-\u00ad?3203.\t\n \u00a0\t\n \u00a0\t\n \u00a0\n\n\t\n \u00a0\nZHANG,\t\n \u00a0 Y.\t\n \u00a0 F.\t\n \u00a0 \t\n \u00a0 et\t\n \u00a0 al.\t\n \u00a0 Effect\t\n \u00a0 of\t\n \u00a0 angiotensin\t\n \u00a0 II\t\n \u00a0 type\t\n \u00a0 I\t\n \u00a0 receptor\t\n \u00a0 blocker\t\n \u00a0 losartan\t\n \u00a0 on\t\n \u00a0 bone\t\n \u00a0\ndeterioration\t\n \u00a0in\t\n \u00a0orchiectomized\t\n \u00a0male\t\n \u00a0hypertensive\t\n \u00a0and\t\n \u00a0normotensive\t\n \u00a0rats.\t\n \u00a0Chin\t\n \u00a0Med\t\n \u00a0J\t\n \u00a0(Engl),\t\n \u00a0\nv.\t\n \u00a0126,\t\n \u00a0n.\t\n \u00a014,\t\n \u00a0p.\t\n \u00a02661-\u00ad?5,\t\n \u00a0Jul\t\n \u00a02013.\t\n \u00a0ISSN\t\n \u00a00366-\u00ad?6999\t\n \u00a0(Print)\t\n \u00a0\n\n0366-\u00ad?6999."}]}}}